Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:antiamoebic agent
go back to main search page
Accession:CHEBI:171664 term browser browse the term
Definition:An antiparasitic agent which is effective against amoeba, a genus of single-celled amoeboids in the family Amoebidae.
Synonyms:related_synonym: amebicide;   amebicides;   amoebicide;   amoebicides;   anti-amoebic agent;   anti-amoebic agents;   anti-amoebic drug;   anti-amoebic drugs;   antiamoebic;   antiamoebic agents;   antiamoebic drug;   antiamoebic drugs;   antiamoebics



show annotations for term's descendants           Sort by:
 
amphotericin B term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ARHGEF26 Rho guanine nucleotide exchange factor 26 increases expression EXP Amphotericin B results in increased expression of ARHGEF26 mRNA CTD PMID:20849824 NCBI chr 3:154,121,003...154,257,825
Ensembl chr 3:154,121,003...154,257,827
JBrowse link
G ARNT aryl hydrocarbon receptor nuclear translocator multiple interactions EXP Amphotericin B inhibits the reaction [[HIF1A protein binds to ARNT protein] which binds to EPO enhancer] CTD PMID:16189267 NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708
JBrowse link
G ATG3 autophagy related 3 decreases expression EXP Amphotericin B results in decreased expression of ATG3 mRNA CTD PMID:20849824 NCBI chr 3:112,532,510...112,561,962
Ensembl chr 3:112,532,510...112,562,046
JBrowse link
G CASP3 caspase 3 increases expression ISO Amphotericin B results in increased expression of CASP3 protein CTD PMID:23988732 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
JBrowse link
G CAT catalase decreases expression ISO Amphotericin B results in decreased expression of CAT mRNA CTD PMID:20623750 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CCR2 C-C motif chemokine receptor 2 decreases expression ISO Amphotericin B results in decreased expression of CCR2 mRNA CTD PMID:20623750 NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
JBrowse link
G CLU clusterin affects expression ISO Amphotericin B affects the expression of CLU mRNA CTD PMID:20623750 NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 increases expression
multiple interactions
EXP Amphotericin B results in increased expression of CXCL8 mRNA
[Amphotericin B co-treated with lipopolysaccharide, E. coli O26-B6] results in increased expression of CXCL8 mRNA
CTD PMID:29594315 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
JBrowse link
G EDNRB endothelin receptor type B increases expression EXP Amphotericin B results in increased expression of EDNRB mRNA CTD PMID:20849824 NCBI chr13:77,895,481...77,975,527
Ensembl chr13:77,895,481...77,975,529
JBrowse link
G ENO1 enolase 1 multiple interactions EXP Amphotericin B inhibits the reaction [Oxygen deficiency results in increased expression of ENO1 mRNA]; Amphotericin B results in increased expression of and results in increased secretion of ENO1 protein CTD PMID:16189267 PMID:26259607 NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
JBrowse link
G EP300 E1A binding protein p300 multiple interactions EXP Amphotericin B inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]] CTD PMID:16189267 NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,592...41,180,077
JBrowse link
G EPO erythropoietin multiple interactions
decreases expression
EXP
ISO
Amphotericin B inhibits the reaction [[HIF1A protein binds to ARNT protein] which binds to EPO enhancer]; Amphotericin B inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]
Amphotericin B results in decreased expression of EPO protein
CTD PMID:697352 PMID:2299214 PMID:16189267 NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
JBrowse link
G GLOD4 glyoxalase domain containing 4 decreases expression EXP Amphotericin B results in decreased expression of GLOD4 mRNA CTD PMID:20849824 NCBI chr17:759,330...785,895
Ensembl chr17:757,097...782,294
JBrowse link
G GPR20 G protein-coupled receptor 20 increases expression EXP Amphotericin B results in increased expression of GPR20 mRNA CTD PMID:20849824 NCBI chr 8:141,356,470...141,367,286
Ensembl chr 8:141,356,470...141,367,286
JBrowse link
G GSTP1 glutathione S-transferase pi 1 decreases expression
multiple interactions
ISO
EXP
Amphotericin B results in decreased expression of GSTP1 mRNA
Amphotericin B inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD PMID:20623750 PMID:23769903 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
JBrowse link
G GSTT1 glutathione S-transferase theta 1 decreases expression ISO Amphotericin B results in decreased expression of GSTT1 mRNA CTD PMID:20623750
G HIF1A hypoxia inducible factor 1 subunit alpha multiple interactions
decreases activity
EXP Amphotericin B inhibits the reaction [[HIF1A protein binds to ARNT protein] which binds to EPO enhancer]; Amphotericin B inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; Amphotericin B promotes the reaction [HIF1AN protein binds to and results in increased hydroxylation of and results in decreased activity of HIF1A protein]
Amphotericin B results in decreased activity of HIF1A protein
CTD PMID:16189267 NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
JBrowse link
G HIF1AN hypoxia inducible factor 1 subunit alpha inhibitor multiple interactions EXP Amphotericin B promotes the reaction [HIF1AN protein binds to and results in increased hydroxylation of and results in decreased activity of HIF1A protein] CTD PMID:16189267 NCBI chr10:100,535,943...100,559,998
Ensembl chr10:100,529,072...100,559,998
JBrowse link
G HLA-F major histocompatibility complex, class I, F increases expression EXP Amphotericin B results in increased expression of HLA-F mRNA CTD PMID:20849824 NCBI chr 6:29,723,434...29,738,532
Ensembl chr 6:29,722,775...29,738,528
JBrowse link
G HSPA8 heat shock protein family A (Hsp70) member 8 multiple interactions EXP Amphotericin B results in increased expression of and results in increased secretion of HSPA8 protein CTD PMID:26259607 NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
JBrowse link
G IFNG interferon gamma multiple interactions EXP [Amphotericin B co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA; [Antimony Sodium Gluconate co-treated with Amphotericin B] results in increased expression of IFNG protein CTD PMID:17911647 PMID:29594315 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
JBrowse link
G IFNGR1 interferon gamma receptor 1 increases expression EXP Amphotericin B results in increased expression of IFNGR1 CTD PMID:12803856 NCBI chr 6:137,197,484...137,219,385
Ensembl chr 6:137,197,483...137,219,449
JBrowse link
G IGFBP5 insulin like growth factor binding protein 5 decreases expression EXP Amphotericin B results in decreased expression of IGFBP5 mRNA CTD PMID:20849824 NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549
JBrowse link
G IL10 interleukin 10 multiple interactions EXP [Antimony Sodium Gluconate co-treated with Amphotericin B] results in decreased expression of IL10 protein CTD PMID:17911647 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
JBrowse link
G IL1B interleukin 1 beta increases expression EXP Amphotericin B results in increased expression of IL1B mRNA CTD PMID:29594315 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G IL2 interleukin 2 multiple interactions EXP [Amphotericin B co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA CTD PMID:29594315 NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
JBrowse link
G KCNQ4 potassium voltage-gated channel subfamily Q member 4 decreases expression EXP Amphotericin B results in decreased expression of KCNQ4 mRNA CTD PMID:20849824 NCBI chr 1:40,783,787...40,840,452
Ensembl chr 1:40,783,787...40,840,452
JBrowse link
G LSG1 large 60S subunit nuclear export GTPase 1 decreases expression EXP Amphotericin B results in decreased expression of LSG1 mRNA CTD PMID:20849824 NCBI chr 3:194,640,791...194,672,191
Ensembl chr 3:194,640,791...194,672,463
JBrowse link
G MAP1LC3B microtubule associated protein 1 light chain 3 beta increases expression ISO Amphotericin B results in increased expression of MAP1LC3B protein CTD PMID:23988732 NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
JBrowse link
G NPRL2 NPR2 like, GATOR1 complex subunit decreases expression EXP Amphotericin B results in decreased expression of NPRL2 mRNA CTD PMID:20849824 NCBI chr 3:50,347,330...50,350,775
Ensembl chr 3:50,347,330...50,350,826
JBrowse link
G NT5C2 5'-nucleotidase, cytosolic II increases expression EXP Amphotericin B results in increased expression of NT5C2 mRNA CTD PMID:20849824 NCBI chr10:103,088,017...103,193,272
Ensembl chr10:103,087,185...103,277,605
JBrowse link
G PAIP1 poly(A) binding protein interacting protein 1 decreases expression EXP Amphotericin B results in decreased expression of PAIP1 mRNA CTD PMID:20849824 NCBI chr 5:43,526,267...43,557,411
Ensembl chr 5:43,526,267...43,557,758
JBrowse link
G PARD3 par-3 family cell polarity regulator decreases expression EXP Amphotericin B results in decreased expression of PARD3 mRNA CTD PMID:20849824 NCBI chr10:34,109,561...34,815,296
Ensembl chr10:34,109,560...34,815,325
JBrowse link
G PGK1 phosphoglycerate kinase 1 multiple interactions EXP Amphotericin B inhibits the reaction [Oxygen deficiency results in increased expression of PGK1 mRNA] CTD PMID:16189267 NCBI chr  X:78,104,248...78,129,295
Ensembl chr  X:77,910,739...78,129,295
JBrowse link
G POLM DNA polymerase mu increases expression EXP Amphotericin B results in increased expression of POLM mRNA CTD PMID:20849824 NCBI chr 7:44,072,062...44,082,530
Ensembl chr 7:44,072,062...44,082,530
JBrowse link
G RUNX3 RUNX family transcription factor 3 decreases expression EXP Amphotericin B results in decreased expression of RUNX3 mRNA CTD PMID:20849824 NCBI chr 1:24,899,511...24,965,138
Ensembl chr 1:24,899,511...24,965,121
JBrowse link
G SLIT1 slit guidance ligand 1 decreases expression EXP Amphotericin B results in decreased expression of SLIT1 mRNA CTD PMID:20849824 NCBI chr10:96,998,038...97,185,959
Ensembl chr10:96,998,038...97,185,959
JBrowse link
G SPP1 secreted phosphoprotein 1 affects expression ISO Amphotericin B affects the expression of SPP1 mRNA CTD PMID:20623750 NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
JBrowse link
G TGFB1 transforming growth factor beta 1 multiple interactions EXP [Antimony Sodium Gluconate co-treated with Amphotericin B] results in decreased expression of TGFB1 protein CTD PMID:17911647 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
JBrowse link
G TMPRSS2 transmembrane serine protease 2 increases expression EXP Amphotericin B results in increased expression of TMPRSS2 mRNA CTD PMID:32808185 NCBI chr21:41,464,305...41,508,158
Ensembl chr21:41,464,300...41,531,116
JBrowse link
G TNF tumor necrosis factor increases expression ISO Amphotericin B results in increased expression of TNF mRNA CTD PMID:20623750 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G UGT1A9 UDP glucuronosyltransferase family 1 member A9 affects expression ISO Amphotericin B affects the expression of UGT1A9 mRNA CTD PMID:20623750 NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300
JBrowse link
G USP36 ubiquitin specific peptidase 36 increases expression EXP Amphotericin B results in increased expression of USP36 mRNA CTD PMID:20849824 NCBI chr17:78,787,381...78,841,439
Ensembl chr17:78,787,381...78,841,441
JBrowse link
G ZNF671 zinc finger protein 671 decreases expression EXP Amphotericin B results in decreased expression of ZNF671 mRNA CTD PMID:20849824 NCBI chr19:57,719,751...57,727,624
Ensembl chr19:57,719,751...57,727,624
JBrowse link
amphotericin B methyl ester term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HAVCR1 hepatitis A virus cellular receptor 1 increases expression ISO methylamphotericin B results in increased expression of HAVCR1 mRNA CTD PMID:22863853 NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,029,413...157,059,119
JBrowse link
G LCN2 lipocalin 2 increases expression ISO methylamphotericin B results in increased expression of LCN2 mRNA CTD PMID:22863853 NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
JBrowse link
G SPP1 secreted phosphoprotein 1 increases expression ISO methylamphotericin B results in increased expression of SPP1 mRNA CTD PMID:22863853 NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
JBrowse link
G TIMP1 TIMP metallopeptidase inhibitor 1 increases expression ISO methylamphotericin B results in increased expression of TIMP1 mRNA CTD PMID:22863853 NCBI chr  X:47,582,436...47,586,789
Ensembl chr  X:47,582,408...47,586,789
JBrowse link
emetine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AGO3 argonaute RISC catalytic component 3 multiple interactions ISO Emetine inhibits the reaction [Thapsigargin affects the localization of AGO3 mRNA] CTD PMID:29576526 NCBI chr 1:35,930,718...36,072,500
Ensembl chr 1:35,930,718...36,072,500
JBrowse link
G AKAP9 A-kinase anchoring protein 9 multiple interactions EXP Emetine inhibits the reaction [sodium arsenite affects the localization of AKAP9 protein] CTD PMID:19073175 NCBI chr 7:91,940,862...92,110,673
Ensembl chr 7:91,940,840...92,110,673
JBrowse link
G AR androgen receptor multiple interactions EXP Emetine binds to and results in decreased activity of AR protein CTD PMID:25752796 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619
JBrowse link
G BRCA1 BRCA1 DNA repair associated multiple interactions ISO Emetine inhibits the reaction [Thapsigargin affects the localization of BRCA1 mRNA] CTD PMID:29576526 NCBI chr17:43,044,295...43,125,364
Ensembl chr17:43,044,295...43,170,245
JBrowse link
G CAPRIN1 cell cycle associated protein 1 multiple interactions EXP Emetine inhibits the reaction [sodium arsenite affects the localization of CAPRIN1 protein] CTD PMID:19073175 NCBI chr11:34,051,731...34,102,610
Ensembl chr11:34,051,731...34,102,610
JBrowse link
G CASP3 caspase 3 increases activity ISO Emetine results in increased activity of CASP3 protein CTD PMID:14502240 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
JBrowse link
G CASP9 caspase 9 increases activity ISO Emetine results in increased activity of CASP9 protein CTD PMID:14502240 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
JBrowse link
G CCAR1 cell division cycle and apoptosis regulator 1 multiple interactions EXP Emetine inhibits the reaction [sodium arsenite affects the localization of CCAR1 protein] CTD PMID:19073175 NCBI chr10:68,721,239...68,792,377
Ensembl chr10:68,721,012...68,792,377
JBrowse link
G CCL2 C-C motif chemokine ligand 2 decreases expression EXP Emetine results in decreased expression of CCL2 protein CTD PMID:20116850 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
JBrowse link
G CCL3 C-C motif chemokine ligand 3 decreases expression EXP Emetine results in decreased expression of CCL3 protein CTD PMID:20116850 NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
JBrowse link
G CCL4 C-C motif chemokine ligand 4 decreases expression EXP Emetine results in decreased expression of CCL4 protein CTD PMID:20116850 NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
JBrowse link
G CCL5 C-C motif chemokine ligand 5 decreases expression EXP Emetine results in decreased expression of CCL5 protein CTD PMID:20116850 NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
JBrowse link
G CREB1 cAMP responsive element binding protein 1 multiple interactions ISO Emetine inhibits the reaction [Thapsigargin affects the localization of CREB1 mRNA] CTD PMID:29576526 NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 decreases expression EXP Emetine results in decreased expression of CXCL8 protein CTD PMID:20116850 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
JBrowse link
G ESR1 estrogen receptor 1 multiple interactions EXP Emetine binds to and results in decreased activity of ESR1 protein CTD PMID:25752796 NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
JBrowse link
G ESR2 estrogen receptor 2 multiple interactions EXP Emetine binds to and results in decreased activity of ESR2 protein CTD PMID:25752796 NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
JBrowse link
G IL6R interleukin 6 receptor decreases expression EXP Emetine results in decreased expression of IL6R protein modified form CTD PMID:20116850 NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions
decreases phosphorylation
increases phosphorylation
ISO
EXP
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Emetine results in increased phosphorylation of MAPK1 protein]
MAPK14 mutant form inhibits the reaction [Emetine results in decreased phosphorylation of MAPK1 protein]
CTD PMID:15772366 PMID:26332055 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
JBrowse link
G MAPK14 mitogen-activated protein kinase 14 multiple interactions EXP Emetine results in increased phosphorylation of and results in increased activity of MAPK14 protein; MAPK14 mutant form inhibits the reaction [Emetine results in decreased activity of MMP2 protein]; MAPK14 mutant form inhibits the reaction [Emetine results in decreased activity of MMP9 protein]; MAPK14 mutant form inhibits the reaction [Emetine results in decreased phosphorylation of MAPK1 protein]; MAPK14 mutant form inhibits the reaction [Emetine results in decreased phosphorylation of MAPK3 protein] CTD PMID:16364386 PMID:26332055 NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,677...36,111,236
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 increases phosphorylation
decreases phosphorylation
multiple interactions
ISO
EXP
Emetine results in increased phosphorylation of MAPK3 protein
Emetine results in decreased phosphorylation of MAPK3 protein
MAPK14 mutant form inhibits the reaction [Emetine results in decreased phosphorylation of MAPK3 protein]
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Emetine results in increased phosphorylation of MAPK3 protein]
CTD PMID:15772366 PMID:26332055 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G MAPK8 mitogen-activated protein kinase 8 multiple interactions
increases phosphorylation
ISO 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Emetine results in increased phosphorylation of MAPK8 protein] CTD PMID:15772366 NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
JBrowse link
G MAPK9 mitogen-activated protein kinase 9 multiple interactions
increases phosphorylation
ISO 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Emetine results in increased phosphorylation of MAPK9 protein] CTD PMID:15772366 NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
JBrowse link
G MAPT microtubule associated protein tau decreases expression EXP Emetine results in decreased expression of MAPT protein CTD PMID:16930453 NCBI chr17:45,894,554...46,028,334
Ensembl chr17:45,894,527...46,028,334
JBrowse link
G MMP2 matrix metallopeptidase 2 decreases activity
multiple interactions
decreases expression
EXP Emetine results in decreased activity of MMP2 protein
MAPK14 mutant form inhibits the reaction [Emetine results in decreased activity of MMP2 protein]
Emetine results in decreased expression of MMP2 mRNA
CTD PMID:26332055 NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
JBrowse link
G MMP9 matrix metallopeptidase 9 decreases activity
multiple interactions
decreases expression
EXP Emetine results in decreased activity of MMP9 protein
MAPK14 mutant form inhibits the reaction [Emetine results in decreased activity of MMP9 protein]
Emetine results in decreased expression of MMP9 mRNA
CTD PMID:26332055 NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
JBrowse link
G NR1H4 nuclear receptor subfamily 1 group H member 4 multiple interactions EXP Emetine inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] CTD PMID:25257666 NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 increases cleavage EXP Emetine results in increased cleavage of PARP1 protein CTD PMID:21256112 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
JBrowse link
G PGR progesterone receptor multiple interactions EXP Emetine binds to and results in decreased activity of PGR protein CTD PMID:25752796 NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
JBrowse link
G RECK reversion inducing cysteine rich protein with kazal motifs decreases expression EXP Emetine results in decreased expression of RECK mRNA CTD PMID:26332055 NCBI chr 9:36,036,913...36,124,455
Ensembl chr 9:36,036,913...36,124,455
JBrowse link
G RICTOR RPTOR independent companion of MTOR complex 2 multiple interactions ISO Emetine inhibits the reaction [Thapsigargin affects the localization of RICTOR mRNA] CTD PMID:29576526 NCBI chr 5:38,937,920...39,074,399
Ensembl chr 5:38,937,920...39,074,399
JBrowse link
G TARDBP TAR DNA binding protein multiple interactions ISO Emetine affects the reaction [TARDBP protein binds to TIA1 protein]; Emetine affects the reaction [TARDBP protein binds to TIAR protein] CTD PMID:19765185 NCBI chr 1:11,012,654...11,030,528
Ensembl chr 1:11,012,344...11,030,528
JBrowse link
G TGFB1 transforming growth factor beta 1 decreases activity EXP Emetine results in decreased activity of TGFB1 protein CTD PMID:31652400 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
JBrowse link
G THRA thyroid hormone receptor alpha multiple interactions EXP Emetine binds to and results in decreased activity of THRA protein CTD PMID:25752796 NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867
JBrowse link
G THRB thyroid hormone receptor beta multiple interactions EXP Emetine binds to and results in decreased activity of THRB protein CTD PMID:25752796 NCBI chr 3:24,117,153...24,495,708
Ensembl chr 3:24,117,153...24,495,756
JBrowse link
G TIA1 TIA1 cytotoxic granule associated RNA binding protein multiple interactions ISO Emetine affects the reaction [TARDBP protein binds to TIA1 protein] CTD PMID:19765185 NCBI chr 2:70,209,444...70,248,793
Ensembl chr 2:70,209,444...70,248,660
JBrowse link
G TIAL1 TIA1 cytotoxic granule associated RNA binding protein like 1 multiple interactions ISO Emetine affects the reaction [TARDBP protein binds to TIAR protein] CTD PMID:19765185 NCBI chr10:119,573,465...119,596,964
Ensembl chr10:119,571,802...119,597,029
JBrowse link
G VEGFA vascular endothelial growth factor A decreases expression EXP Emetine results in decreased expression of VEGFA protein CTD PMID:20116850 NCBI chr 6:43,770,209...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
G XIAP X-linked inhibitor of apoptosis multiple interactions ISO Emetine inhibits the reaction [Thapsigargin affects the localization of XIAP mRNA] CTD PMID:29576526 NCBI chr  X:123,859,708...123,913,972
Ensembl chr  X:123,859,724...123,913,976
JBrowse link
iodoquinol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G GSTP1 glutathione S-transferase pi 1 multiple interactions EXP Iodoquinol inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] CTD PMID:23769903 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
JBrowse link
metronidazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC2 ATP binding cassette subfamily C member 2 decreases expression ISO Metronidazole results in decreased expression of ABCC2 mRNA CTD PMID:24657338 NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
JBrowse link
G ABCC3 ATP binding cassette subfamily C member 3 increases expression ISO Metronidazole results in increased expression of ABCC3 mRNA CTD PMID:24657338 NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
JBrowse link
G ABCG8 ATP binding cassette subfamily G member 8 increases expression ISO Metronidazole results in increased expression of ABCG8 mRNA CTD PMID:24657338 NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988
JBrowse link
G ACACA acetyl-CoA carboxylase alpha multiple interactions ISO [Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of ACACA mRNA CTD PMID:34979169 NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
JBrowse link
G ACAT2 acetyl-CoA acetyltransferase 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACAT2 protein CTD PMID:30545405 NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112
JBrowse link
G ACE2 angiotensin converting enzyme 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACE2 protein CTD PMID:30545405 NCBI chr  X:15,518,197...15,607,211
Ensembl chr  X:15,494,566...15,607,236
JBrowse link
G ADIPOQ adiponectin, C1Q and collagen domain containing multiple interactions ISO [Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of ADIPOQ mRNA CTD PMID:34979169 NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
JBrowse link
G AHSG alpha 2-HS glycoprotein multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of AHSG protein CTD PMID:30545405 NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318
JBrowse link
G ALDOA aldolase, fructose-bisphosphate A multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOA protein CTD PMID:30545405 NCBI chr16:30,064,279...30,070,420
Ensembl chr16:30,064,164...30,070,457
JBrowse link
G ALDOB aldolase, fructose-bisphosphate B multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOB protein CTD PMID:30545405 NCBI chr 9:101,420,560...101,435,774
Ensembl chr 9:101,420,560...101,449,664
JBrowse link
G ARG2 arginase 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ARG2 protein CTD PMID:30545405 NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708
JBrowse link
G ARPC3 actin related protein 2/3 complex subunit 3 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ARPC3 protein CTD PMID:30545405 NCBI chr12:110,434,823...110,450,337
Ensembl chr12:110,434,823...110,450,422
JBrowse link
G ASAH1 N-acylsphingosine amidohydrolase 1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ASAH1 protein CTD PMID:30545405 NCBI chr 8:18,055,992...18,084,961
Ensembl chr 8:18,055,992...18,084,998
JBrowse link
G ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP1A1 protein CTD PMID:30545405 NCBI chr 1:116,373,244...116,404,774
Ensembl chr 1:116,372,668...116,410,261
JBrowse link
G ATP2A3 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP2A3 protein CTD PMID:30545405 NCBI chr17:3,923,873...3,964,437
Ensembl chr17:3,923,870...3,964,464
JBrowse link
G ATP5MF ATP synthase membrane subunit f multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5J2 protein CTD PMID:30545405 NCBI chr 7:99,458,195...99,466,167
Ensembl chr 7:99,448,475...99,466,186
JBrowse link
G ATP5PD ATP synthase peripheral stalk subunit d multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5H protein CTD PMID:30545405 NCBI chr17:75,038,863...75,046,969
Ensembl chr17:75,038,863...75,046,985
JBrowse link
G ATP5PF ATP synthase peripheral stalk subunit F6 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5J protein CTD PMID:30545405 NCBI chr21:25,724,500...25,735,653
Ensembl chr21:25,716,503...25,735,673
JBrowse link
G B3GALT5 beta-1,3-galactosyltransferase 5 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of B3GALT5 protein CTD PMID:30545405 NCBI chr21:39,612,940...39,673,137
Ensembl chr21:39,556,442...39,673,137
JBrowse link
G CLCA4 chloride channel accessory 4 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLCA4 protein CTD PMID:30545405 NCBI chr 1:86,547,078...86,580,754
Ensembl chr 1:86,547,078...86,580,754
JBrowse link
G CLDN7 claudin 7 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLDN7 protein CTD PMID:30545405 NCBI chr17:7,259,903...7,263,213
Ensembl chr17:7,259,903...7,263,983
JBrowse link
G CMBL carboxymethylenebutenolidase homolog multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CMBL protein CTD PMID:30545405 NCBI chr 5:10,277,595...10,307,902
Ensembl chr 5:10,275,875...10,307,902
JBrowse link
G CNDP2 carnosine dipeptidase 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein CTD PMID:30545405 NCBI chr18:74,496,363...74,523,454
Ensembl chr18:74,495,816...74,523,454
JBrowse link
G COX5A cytochrome c oxidase subunit 5A multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX5A protein CTD PMID:30545405 NCBI chr15:74,919,791...74,938,073
Ensembl chr15:74,919,791...74,938,083
JBrowse link
G COX6B1 cytochrome c oxidase subunit 6B1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX6B1 protein CTD PMID:30545405 NCBI chr19:35,648,323...35,658,782
Ensembl chr19:35,648,323...35,658,782
JBrowse link
G COX7A2 cytochrome c oxidase subunit 7A2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX7A2 protein CTD PMID:30545405 NCBI chr 6:75,237,675...75,250,298
Ensembl chr 6:75,237,675...75,250,323
JBrowse link
G CSF2 colony stimulating factor 2 multiple interactions ISO [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of CSF2 protein CTD PMID:31442584 NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
JBrowse link
G CTSA cathepsin A multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CTSA protein CTD PMID:30545405 NCBI chr20:45,891,335...45,898,820
Ensembl chr20:45,890,144...45,898,949
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP1A2 mRNA CTD PMID:30545405 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2E1 mRNA CTD PMID:30545405 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 multiple interactions EXP
ISO
Metronidazole inhibits the reaction [CYP3A4 protein results in increased metabolism of Amiodarone]; Metronidazole inhibits the reaction [CYP3A4 protein results in increased metabolism of Tacrolimus]; Metronidazole inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin]
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP3A2 mRNA
CTD PMID:15855244 PMID:15869686 PMID:19299527 PMID:30545405 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G EPCAM epithelial cell adhesion molecule multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EPCAM protein CTD PMID:30545405 NCBI chr 2:47,369,311...47,387,020
Ensembl chr 2:47,345,158...47,387,601
JBrowse link
G EREG epiregulin increases expression EXP Metronidazole results in increased expression of EREG mRNA CTD PMID:32816093 NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749
JBrowse link
G ETFA electron transfer flavoprotein subunit alpha multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ETFA protein CTD PMID:30545405 NCBI chr15:76,215,353...76,311,469
Ensembl chr15:76,188,555...76,311,730
JBrowse link
G EZR ezrin multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EZR protein CTD PMID:30545405 NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,368
JBrowse link
G FASN fatty acid synthase multiple interactions ISO [Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased expression of FASN mRNA] CTD PMID:34979169 NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
JBrowse link
G GFPT2 glutamine-fructose-6-phosphate transaminase 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GFPT2 protein CTD PMID:30545405 NCBI chr 5:180,300,698...180,353,336
Ensembl chr 5:180,300,698...180,353,336
JBrowse link
G GIPC2 GIPC PDZ domain containing family member 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GIPC2 protein CTD PMID:30545405 NCBI chr 1:78,044,970...78,138,444
Ensembl chr 1:77,979,542...78,138,444
JBrowse link
G GNG12 G protein subunit gamma 12 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GNG12 protein CTD PMID:30545405 NCBI chr 1:67,701,475...67,833,467
Ensembl chr 1:67,701,475...67,833,467
JBrowse link
G GPT glutamic--pyruvic transaminase multiple interactions ISO [Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased activity of GPT protein] CTD PMID:34979169 NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
JBrowse link
G GPX1 glutathione peroxidase 1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GPX1 protein CTD PMID:30545405 NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,176...49,358,353
JBrowse link
G GSTM2 glutathione S-transferase mu 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTM2 mRNA CTD PMID:30545405 NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
JBrowse link
G HEXB hexosaminidase subunit beta multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of HEXB protein CTD PMID:30545405 NCBI chr 5:74,640,023...74,721,288
Ensembl chr 5:74,640,023...74,722,647
JBrowse link
G HLA-DMB major histocompatibility complex, class II, DM beta multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RT1-DMB protein CTD PMID:30545405 NCBI chr 6:32,934,636...32,941,028
Ensembl chr 6:32,934,629...32,941,028
JBrowse link
G HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 affects expression EXP Metronidazole affects the expression of HLA-DQB1 mRNA CTD PMID:25811541 NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
JBrowse link
G HLA-DRB1 major histocompatibility complex, class II, DR beta 1 affects expression EXP Metronidazole affects the expression of HLA-DRB1 mRNA CTD PMID:25811541 NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
JBrowse link
G HNRNPH2 heterogeneous nuclear ribonucleoprotein H2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HNRNPH2 protein CTD PMID:30545405 NCBI chr  X:101,408,222...101,414,133
Ensembl chr  X:101,408,222...101,414,133
JBrowse link
G HP haptoglobin multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HP protein CTD PMID:30545405 NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
JBrowse link
G IL24 interleukin 24 increases expression EXP Metronidazole results in increased expression of IL24 mRNA CTD PMID:32816093 NCBI chr 1:206,897,443...206,904,139
Ensembl chr 1:206,897,443...206,904,139
JBrowse link
G IL6 interleukin 6 multiple interactions ISO [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein] CTD PMID:31442584 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G KNG1 kininogen 1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MAP1 protein CTD PMID:30545405 NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410
JBrowse link
G KRT16 keratin 16 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of KRT16 protein CTD PMID:30545405 NCBI chr17:41,609,778...41,612,767
Ensembl chr17:41,609,778...41,615,899
JBrowse link
G LEP leptin multiple interactions ISO [Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of LEP mRNA CTD PMID:34979169 NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
JBrowse link
G LYZ lysozyme multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of LYZ2 protein CTD PMID:30545405 NCBI chr12:69,348,381...69,354,234
Ensembl chr12:69,348,381...69,354,234
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MAPK3 protein CTD PMID:30545405 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G MLXIP MLX interacting protein multiple interactions ISO [Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased expression of MLXIP mRNA] CTD PMID:34979169 NCBI chr12:122,078,756...122,147,344
Ensembl chr12:122,078,756...122,147,344
JBrowse link
G MYH14 myosin heavy chain 14 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MYH14 protein CTD PMID:30545405 NCBI chr19:50,203,622...50,310,540
Ensembl chr19:50,188,186...50,310,542
JBrowse link
G NDUFA13 NADH:ubiquinone oxidoreductase subunit A13 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFA13 protein CTD PMID:30545405 NCBI chr19:19,516,225...19,528,198
Ensembl chr19:19,515,736...19,529,054
JBrowse link
G NDUFAB1 NADH:ubiquinone oxidoreductase subunit AB1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein CTD PMID:30545405 NCBI chr16:23,581,014...23,596,316
Ensembl chr16:23,581,014...23,596,316
JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions ISO Metronidazole inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] CTD PMID:12568917 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
JBrowse link
G NPC2 NPC intracellular cholesterol transporter 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of NPC2 protein CTD PMID:30545405 NCBI chr14:74,479,935...74,493,512
Ensembl chr14:74,476,192...74,494,177
JBrowse link
G PFN1 profilin 1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PFN1 protein CTD PMID:30545405 NCBI chr17:4,945,652...4,948,530
Ensembl chr17:4,945,652...4,949,061
JBrowse link
G PGAM1 phosphoglycerate mutase 1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PGAM1 protein CTD PMID:30545405 NCBI chr10:97,426,191...97,433,444
Ensembl chr10:97,426,191...97,433,444
JBrowse link
G PMM2 phosphomannomutase 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PMM2 protein CTD PMID:30545405 NCBI chr16:8,797,839...8,849,325
Ensembl chr16:8,788,823...8,862,534
JBrowse link
G PPP1CA protein phosphatase 1 catalytic subunit alpha multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CA protein CTD PMID:30545405 NCBI chr11:67,398,183...67,401,858
Ensembl chr11:67,398,181...67,421,183
JBrowse link
G PPP1CB protein phosphatase 1 catalytic subunit beta multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CB protein CTD PMID:30545405 NCBI chr 2:28,751,604...28,802,940
Ensembl chr 2:28,751,640...28,802,940
JBrowse link
G PPP1CC protein phosphatase 1 catalytic subunit gamma multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CC protein CTD PMID:30545405 NCBI chr12:110,708,376...110,742,891
Ensembl chr12:110,719,680...110,742,939
JBrowse link
G PSMA3 proteasome 20S subunit alpha 3 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of PSMA3 protein CTD PMID:30545405 NCBI chr14:58,244,843...58,272,004
Ensembl chr14:58,244,843...58,272,012
JBrowse link
G RALB RAS like proto-oncogene B multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RALB protein CTD PMID:30545405 NCBI chr 2:120,240,070...120,294,710
Ensembl chr 2:120,240,064...120,294,710
JBrowse link
G RAN RAN, member RAS oncogene family multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RAN protein CTD PMID:30545405 NCBI chr12:130,872,066...130,877,678
Ensembl chr12:130,872,037...130,877,678
JBrowse link
G RIDA reactive intermediate imine deaminase A homolog multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RIDA protein CTD PMID:30545405 NCBI chr 8:98,102,344...98,117,171
Ensembl chr 8:98,102,344...98,117,171
JBrowse link
G RPL30 ribosomal protein L30 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPL30 protein CTD PMID:30545405 NCBI chr 8:98,041,721...98,045,545
Ensembl chr 8:98,024,851...98,046,469
JBrowse link
G RPN2 ribophorin II multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPN2 protein CTD PMID:30545405 NCBI chr20:37,179,330...37,241,619
Ensembl chr20:37,178,410...37,241,619
JBrowse link
G RPS23 ribosomal protein S23 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPS23 protein CTD PMID:30545405 NCBI chr 5:82,273,320...82,278,354
Ensembl chr 5:82,273,320...82,278,396
JBrowse link
G RPS27L ribosomal protein S27 like multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPS27L protein CTD PMID:30545405 NCBI chr15:63,148,249...63,157,477
Ensembl chr15:63,125,872...63,158,021
JBrowse link
G S100A10 S100 calcium binding protein A10 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A10 protein CTD PMID:30545405 NCBI chr 1:151,982,915...151,993,859
Ensembl chr 1:151,982,915...151,993,859
JBrowse link
G S100A11 S100 calcium binding protein A11 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A11 protein CTD PMID:30545405 NCBI chr 1:152,032,506...152,037,004
Ensembl chr 1:152,032,506...152,047,907
JBrowse link
G SCARB2 scavenger receptor class B member 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of SCARB2 protein CTD PMID:30545405 NCBI chr 4:76,158,737...76,234,532
Ensembl chr 4:76,158,737...76,234,536
JBrowse link
G SERPINB6 serpin family B member 6 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SERPINB6 protein CTD PMID:30545405 NCBI chr 6:2,948,159...2,971,793
Ensembl chr 6:2,948,159...2,972,165
JBrowse link
G SHMT2 serine hydroxymethyltransferase 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SHMT2 protein CTD PMID:30545405 NCBI chr12:57,229,711...57,234,935
Ensembl chr12:57,229,573...57,234,935
JBrowse link
G SLC3A1 solute carrier family 3 member 1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SLC3A1 protein CTD PMID:30545405 NCBI chr 2:44,275,480...44,322,437
Ensembl chr 2:44,275,458...44,321,494
JBrowse link
G SLC51B solute carrier family 51 subunit beta decreases expression ISO Metronidazole results in decreased expression of SLC51B mRNA CTD PMID:24657338 NCBI chr15:65,045,387...65,053,397
Ensembl chr15:65,045,387...65,053,397
JBrowse link
G SLCO2B1 solute carrier organic anion transporter family member 2B1 increases expression ISO Metronidazole results in increased expression of SLCO2B1 mRNA CTD PMID:24657338 NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549
JBrowse link
G SMPD2 sphingomyelin phosphodiesterase 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SMPD2 protein CTD PMID:30545405 NCBI chr 6:109,440,724...109,443,919
Ensembl chr 6:109,440,724...109,443,919
JBrowse link
G TARS1 threonyl-tRNA synthetase 1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TARS protein CTD PMID:30545405 NCBI chr 5:33,440,696...33,468,091
Ensembl chr 5:33,440,696...33,468,091
JBrowse link
G TM9SF2 transmembrane 9 superfamily member 2 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TM9SF2 protein CTD PMID:30545405 NCBI chr13:99,501,472...99,564,048
Ensembl chr13:99,446,311...99,564,048
JBrowse link
G TMED10 transmembrane p24 trafficking protein 10 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TMED10 protein CTD PMID:30545405 NCBI chr14:75,131,469...75,176,612
Ensembl chr14:75,131,469...75,176,612
JBrowse link
G TNF tumor necrosis factor multiple interactions ISO [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of TNF protein; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of TNF protein] CTD PMID:31442584 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TUBAL3 tubulin alpha like 3 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein CTD PMID:30545405 NCBI chr10:5,393,101...5,404,828
Ensembl chr10:5,393,101...5,404,828
JBrowse link
G TWF1 twinfilin actin binding protein 1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TWF1 protein CTD PMID:30545405 NCBI chr12:43,793,723...43,806,317
Ensembl chr12:43,793,723...43,806,328
JBrowse link
G TXNDC5 thioredoxin domain containing 5 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein CTD PMID:30545405 NCBI chr 6:7,881,517...7,910,788
Ensembl chr 6:7,881,517...7,910,788
JBrowse link
G UQCRC1 ubiquinol-cytochrome c reductase core protein 1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRC1 protein CTD PMID:30545405 NCBI chr 3:48,599,002...48,609,646
Ensembl chr 3:48,599,002...48,610,976
JBrowse link
G UQCRFS1 ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRFS1 protein CTD PMID:30545405 NCBI chr19:29,205,320...29,213,151
Ensembl chr19:29,205,320...29,213,151
JBrowse link
G UQCRH ubiquinol-cytochrome c reductase hinge protein multiple interactions ISO [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRH protein CTD PMID:30545405 NCBI chr 1:46,303,698...46,316,776
Ensembl chr 1:46,303,698...46,316,776
JBrowse link
ornidazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PLAU plasminogen activator, urokinase decreases expression ISO Ornidazole results in decreased expression of PLAU mRNA; Ornidazole results in decreased expression of PLAU protein CTD PMID:18998460 NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
JBrowse link
rifampicin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AADAC arylacetamide deacetylase multiple interactions
increases hydrolysis
decreases acetylation
EXP AADAC mRNA affects the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; bis(4-nitrophenyl)phosphate inhibits the reaction [AADAC protein results in decreased acetylation of Rifampin]; Isoflurophate inhibits the reaction [AADAC protein results in decreased acetylation of Rifampin]; Phenylmethylsulfonyl Fluoride inhibits the reaction [AADAC protein results in decreased acetylation of Rifampin]; Physostigmine inhibits the reaction [AADAC protein results in decreased acetylation of Rifampin]; Sodium Fluoride inhibits the reaction [AADAC protein results in decreased acetylation of Rifampin]
AADAC protein results in increased hydrolysis of Rifampin
CTD PMID:21856291 PMID:22207054 NCBI chr 3:151,814,116...151,828,488
Ensembl chr 3:151,814,073...151,828,488
JBrowse link
G ABCA1 ATP binding cassette subfamily A member 1 decreases expression
increases expression
EXP Rifampin results in decreased expression of ABCA1 mRNA; Rifampin results in decreased expression of ABCA1 protein
Rifampin results in increased expression of ABCA1 mRNA; Rifampin results in increased expression of ABCA1 protein
CTD PMID:15883047 PMID:17088262 NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
JBrowse link
G ABCA2 ATP binding cassette subfamily A member 2 increases expression EXP Rifampin results in increased expression of ABCA2 mRNA CTD PMID:27199754 NCBI chr 9:137,007,234...137,028,922
Ensembl chr 9:137,007,234...137,028,915
JBrowse link
G ABCA8 ATP binding cassette subfamily A member 8 decreases expression EXP Rifampin results in decreased expression of ABCA8 mRNA CTD PMID:27199754 NCBI chr17:68,867,289...68,955,392
Ensembl chr17:68,867,289...68,955,392
JBrowse link
G ABCB1 ATP binding cassette subfamily B member 1 affects activity
increases expression
multiple interactions
decreases activity
EXP
ISO
Rifampin affects the activity of ABCB1 protein
Rifampin results in increased expression of ABCB1 mRNA; Rifampin results in increased expression of ABCB1 protein
[Rifampin metabolite results in decreased activity of ABCB1A protein] which results in decreased abundance of Adenosine Triphosphate
[NR1I2 protein results in increased susceptibility to Rifampin] which results in increased expression of ABCB1 mRNA; [NR1I2 protein results in increased susceptibility to Rifampin] which results in increased expression of ABCB1 protein; [Rifampin binds to and results in increased activity of NR1I2 protein] promotes the reaction [ABCB1 protein results in decreased uptake of Doxorubicin]; [Rifampin results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 protein; Camptothecin inhibits the reaction [Rifampin results in increased expression of ABCB1 mRNA]; Ketoconazole inhibits the reaction [NR1I2 protein promotes the reaction [Rifampin results in increased expression of ABCB1 mRNA]]; Ketoconazole inhibits the reaction [NR1I2 protein promotes the reaction [Rifampin results in increased expression of ABCB1 protein]]; Ketoconazole inhibits the reaction [Rifampin results in increased expression of ABCB1 mRNA]; Ketoconazole inhibits the reaction [Rifampin results in increased expression of ABCB1 protein]; mulberroside A inhibits the reaction [[NR1I2 protein results in increased susceptibility to Rifampin] which results in increased expression of ABCB1 mRNA]; mulberroside A inhibits the reaction [[NR1I2 protein results in increased susceptibility to Rifampin] which results in increased expression of ABCB1 protein]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of ABCB1 mRNA]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of ABCB1 protein]; pimecrolimus inhibits the reaction [Rifampin results in increased expression of ABCB1 mRNA]; Resveratrol inhibits the reaction [Rifampin results in increased expression of ABCB1 protein]; Rifampin promotes the reaction [ABCB1 protein results in increased transport of Digoxin]; Rifampin promotes the reaction [NR1I2 protein binds to ABCB1 promoter]
CTD PMID:8632764 PMID:11744607 PMID:14722322 PMID:15276086 PMID:15290871 More... NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
JBrowse link
G ABCB11 ATP binding cassette subfamily B member 11 decreases expression
decreases activity
multiple interactions
EXP
ISO
Rifampin results in decreased expression of ABCB11 mRNA
Rifampin results in decreased activity of ABCB11 protein
Rifampin inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD PMID:12135489 PMID:16837569 PMID:20829430 PMID:24014644 PMID:28437613 NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
JBrowse link
G ABCB4 ATP binding cassette subfamily B member 4 increases expression EXP Rifampin results in increased expression of ABCB4 mRNA CTD PMID:27199754 NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
JBrowse link
G ABCB6 ATP binding cassette subfamily B member 6 (Langereis blood group) increases expression EXP Rifampin results in increased expression of ABCB6 mRNA CTD PMID:27199754 NCBI chr 2:219,209,772...219,218,958
Ensembl chr 2:219,209,772...219,218,994
JBrowse link
G ABCC1 ATP binding cassette subfamily C member 1 increases expression EXP Rifampin results in increased expression of ABCC1 mRNA CTD PMID:17191263 NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
JBrowse link
G ABCC10 ATP binding cassette subfamily C member 10 increases expression EXP Rifampin results in increased expression of ABCC10 mRNA CTD PMID:27199754 NCBI chr 6:43,427,541...43,451,994
Ensembl chr 6:43,427,366...43,450,427
JBrowse link
G ABCC11 ATP binding cassette subfamily C member 11 increases expression EXP Rifampin results in increased expression of ABCC11 mRNA CTD PMID:27199754 NCBI chr16:48,164,819...48,247,539
Ensembl chr16:48,165,773...48,247,568
JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 affects export
increases expression
multiple interactions
EXP ABCC2 protein affects the export of Rifampin
Rifampin results in increased expression of ABCC2; Rifampin results in increased expression of ABCC2 mRNA; Rifampin results in increased expression of ABCC2 protein
[Rifampin co-treated with ABCC2 gene mutant form] results in increased expression of ABCC3 protein
CTD PMID:11836020 PMID:12206135 PMID:15652233 PMID:16837569 PMID:16952291 More... NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
JBrowse link
G ABCC3 ATP binding cassette subfamily C member 3 multiple interactions
increases expression
increases activity
EXP [Rifampin co-treated with ABCC2 gene mutant form] results in increased expression of ABCC3 protein; [Rifampin results in increased activity of NR1I2 protein] which results in increased expression of ABCC3 mRNA; Rifampin inhibits the reaction [decitabine results in increased expression of ABCC3 mRNA]
Rifampin results in increased expression of ABCC3 mRNA
Rifampin results in increased activity of ABCC3 protein
CTD PMID:14570758 PMID:16837569 PMID:16952291 PMID:19041851 PMID:20832446 More... NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
JBrowse link
G ABCC5 ATP binding cassette subfamily C member 5 increases expression EXP Rifampin results in increased expression of ABCC5 mRNA CTD PMID:19041851 NCBI chr 3:183,919,934...184,017,884
Ensembl chr 3:183,919,934...184,017,939
JBrowse link
G ABCC6 ATP binding cassette subfamily C member 6 increases expression EXP Rifampin results in increased expression of ABCC6 mRNA CTD PMID:27199754 NCBI chr16:16,149,565...16,223,494
Ensembl chr16:16,149,565...16,223,522
JBrowse link
G ABCF1 ATP binding cassette subfamily F member 1 increases expression EXP Rifampin results in increased expression of ABCF1 mRNA CTD PMID:27199754 NCBI chr 6:30,571,442...30,591,522
Ensembl chr 6:30,571,393...30,597,179
JBrowse link
G ABCG1 ATP binding cassette subfamily G member 1 increases expression EXP Rifampin results in increased expression of ABCG1 mRNA; Rifampin results in increased expression of ABCG1 protein CTD PMID:12040753 PMID:17088262 NCBI chr21:42,199,689...42,297,244
Ensembl chr21:42,199,689...42,297,244
JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 (Junior blood group) increases expression EXP Rifampin results in increased expression of ABCG2 mRNA CTD PMID:16837569 PMID:27199754 NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
JBrowse link
G ABCG8 ATP binding cassette subfamily G member 8 increases expression EXP Rifampin results in increased expression of ABCG8 mRNA CTD PMID:27199754 NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988
JBrowse link
G ABI3 ABI family member 3 decreases expression EXP Rifampin results in decreased expression of ABI3 mRNA CTD PMID:24552687 NCBI chr17:49,210,707...49,223,225
Ensembl chr17:49,210,411...49,223,225
JBrowse link
G ACACA acetyl-CoA carboxylase alpha increases expression ISO Rifampin results in increased expression of ACACA mRNA CTD PMID:27806127 NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
JBrowse link
G ACE2 angiotensin converting enzyme 2 decreases expression EXP Rifampin results in decreased expression of ACE2 mRNA CTD PMID:32808185 NCBI chr  X:15,518,197...15,607,211
Ensembl chr  X:15,494,566...15,607,236
JBrowse link
G ACTR10 actin related protein 10 increases expression EXP Rifampin results in increased expression of ACTR10 mRNA CTD PMID:24552687 NCBI chr14:58,200,149...58,235,636
Ensembl chr14:58,200,080...58,235,636
JBrowse link
G ADH1C alcohol dehydrogenase 1C (class I), gamma polypeptide increases expression EXP Rifampin results in increased expression of ADH1C mRNA CTD PMID:12040753 NCBI chr 4:99,336,497...99,352,746
Ensembl chr 4:99,336,497...99,352,746
JBrowse link
G ADIPOQ adiponectin, C1Q and collagen domain containing multiple interactions ISO [Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of ADIPOQ mRNA CTD PMID:33412187 NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
JBrowse link
G ADORA2A adenosine A2a receptor decreases expression EXP Rifampin results in decreased expression of ADORA2A mRNA CTD PMID:24552687 NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
JBrowse link
G AGAP2 ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 decreases expression EXP Rifampin results in decreased expression of AGAP2 mRNA CTD PMID:24552687 NCBI chr12:57,723,761...57,742,161
Ensembl chr12:57,723,761...57,742,157
JBrowse link
G AHR aryl hydrocarbon receptor multiple interactions
increases expression
EXP [Rifampin co-treated with Benzo(a)pyrene] results in increased expression of AHR mRNA; [Rifampin co-treated with Monocrotophos] results in decreased expression of AHR mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of AHR protein; NR1I2 protein inhibits the reaction [[Rifampin co-treated with Benzo(a)pyrene] results in increased expression of AHR mRNA]
Rifampin results in increased expression of AHR mRNA; Rifampin results in increased expression of AHR protein
CTD PMID:22733800 PMID:28428138 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
G AKR1B10 aldo-keto reductase family 1 member B10 increases expression
multiple interactions
EXP Rifampin results in increased expression of AKR1B10 mRNA
pazopanib inhibits the reaction [Rifampin results in increased expression of AKR1B10 mRNA]; pimecrolimus inhibits the reaction [Rifampin results in increased expression of AKR1B10 mRNA]
CTD PMID:29356861 NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
JBrowse link
G ALAS1 5'-aminolevulinate synthase 1 increases expression EXP Rifampin results in increased expression of ALAS1 mRNA CTD PMID:24259679 PMID:24552687 NCBI chr 3:52,198,083...52,214,327
Ensembl chr 3:52,198,086...52,214,327
JBrowse link
G ANGPTL3 angiopoietin like 3 decreases expression EXP Rifampin results in decreased expression of ANGPTL3 mRNA CTD PMID:32535746 NCBI chr 1:62,597,520...62,606,313
Ensembl chr 1:62,597,520...62,606,313
JBrowse link
G ANGPTL4 angiopoietin like 4 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of ANGPTL4 mRNA CTD PMID:21127053 NCBI chr19:8,364,155...8,374,370
Ensembl chr19:8,363,289...8,374,370
JBrowse link
G ANKRD65 ankyrin repeat domain 65 decreases expression EXP Rifampin results in decreased expression of ANKRD65 mRNA CTD PMID:24552687 NCBI chr 1:1,418,420...1,421,276
Ensembl chr 1:1,418,420...1,421,769
JBrowse link
G ANKS1B ankyrin repeat and sterile alpha motif domain containing 1B decreases expression EXP Rifampin results in decreased expression of ANKS1B mRNA CTD PMID:24552687 NCBI chr12:98,734,786...99,984,936
Ensembl chr12:98,726,457...99,984,936
JBrowse link
G ANXA5 annexin A5 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of ANXA5 mRNA CTD PMID:21224054 NCBI chr 4:121,667,946...121,696,980
Ensembl chr 4:121,667,946...121,696,995
JBrowse link
G APOB apolipoprotein B affects secretion
multiple interactions
decreases expression
EXP Rifampin affects the secretion of APOB protein
ursodoxicoltaurine inhibits the reaction [Rifampin results in decreased expression of APOB mRNA]
CTD PMID:32535746 NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
JBrowse link
G APOC3 apolipoprotein C3 decreases secretion
decreases expression
EXP Rifampin results in decreased secretion of APOC3 protein
Rifampin results in decreased expression of APOC3 mRNA
CTD PMID:32535746 NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072
JBrowse link
G AQP3 aquaporin 3 (Gill blood group) multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of AQP3 mRNA CTD PMID:21127053 NCBI chr 9:33,441,160...33,447,593
Ensembl chr 9:33,441,156...33,447,596
JBrowse link
G AQP4 aquaporin 4 decreases expression EXP Rifampin results in decreased expression of AQP4 mRNA CTD PMID:24552687 NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
JBrowse link
G ARSJ arylsulfatase family member J decreases expression EXP Rifampin results in decreased expression of ARSJ mRNA CTD PMID:24552687 NCBI chr 4:113,900,284...113,979,647
Ensembl chr 4:113,900,284...113,979,727
JBrowse link
G ATF3 activating transcription factor 3 multiple interactions ISO [Rifampin co-treated with Cobicistat] results in increased expression of ATF3 mRNA CTD PMID:33629115 NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
JBrowse link
G ATF4 activating transcription factor 4 multiple interactions
increases expression
ISO
EXP
ATF4 mutant form inhibits the reaction [Rifampin results in increased expression of HSPA5 protein]
Rifampin results in increased expression of ATF4 mRNA; Rifampin results in increased expression of ATF4 protein
4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of ATF4 protein]
CTD PMID:24638036 PMID:27470132 NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
JBrowse link
G ATF6 activating transcription factor 6 increases expression EXP Rifampin results in increased expression of ATF6 mRNA CTD PMID:32535746 NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
JBrowse link
G ATM ATM serine/threonine kinase multiple interactions
decreases expression
ISO
EXP
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of ATM mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of ATM protein
Rifampin results in decreased expression of ATM mRNA
CTD PMID:21224054 PMID:24552687 NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,223,044...108,369,102
JBrowse link
G ATP6V0A1 ATPase H+ transporting V0 subunit a1 multiple interactions
increases expression
EXP [Rotenone co-treated with Rifampin] results in increased expression of ATP6V0A1 protein; Rifampin inhibits the reaction [Rotenone results in decreased expression of ATP6V0A1 mRNA]; Rotenone inhibits the reaction [Rifampin results in increased expression of ATP6V0A1 protein] CTD PMID:31648047 NCBI chr17:42,458,878...42,522,579
Ensembl chr17:42,458,844...42,522,582
JBrowse link
G ATP6V0D1 ATPase H+ transporting V0 subunit d1 multiple interactions EXP ATP6V0D1 protein affects the reaction [Rifampin inhibits the reaction [Rotenone results in increased lipidation of MAP1LC3B protein]] CTD PMID:31648047 NCBI chr16:67,438,019...67,481,157
Ensembl chr16:67,438,014...67,481,181
JBrowse link
G ATRX ATRX chromatin remodeler increases expression EXP Rifampin results in increased expression of ATRX mRNA CTD PMID:24552687 NCBI chr  X:77,504,880...77,786,216
Ensembl chr  X:77,504,880...77,786,233
JBrowse link
G BAX BCL2 associated X, apoptosis regulator multiple interactions
decreases expression
ISO
EXP
[Isoniazid co-treated with Rifampin] results in increased expression of BAX protein; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BAX mRNA; [Rifampin co-treated with Cobicistat] results in increased expression of BAX mRNA; Ursodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in increased expression of BAX protein]
[Rifampin inhibits the reaction [CYP2C8 protein results in increased susceptibility to Amodiaquine]] which results in increased expression of BAX protein
Rifampin results in decreased expression of BAX protein
CTD PMID:11958592 PMID:12645856 PMID:21224054 PMID:21419764 PMID:31629065 More... NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BCL2 BCL2 apoptosis regulator increases expression
multiple interactions
EXP
ISO
Rifampin results in increased expression of BCL2 protein
[Rifampin inhibits the reaction [CYP2C8 protein results in increased susceptibility to Amodiaquine]] which results in decreased expression of BCL2 protein
[Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein; Ursodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein]
CTD PMID:11958592 PMID:21419764 PMID:31629065 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G BCL2L1 BCL2 like 1 increases expression
multiple interactions
EXP
ISO
Rifampin results in increased expression of BCL2L1 protein
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BCL2L1 mRNA
CTD PMID:11958592 PMID:12645856 PMID:21224054 NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
JBrowse link
G BHLHE40 basic helix-loop-helix family member e40 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of BHLHE40 mRNA CTD PMID:21127053 NCBI chr 3:4,979,437...4,985,323
Ensembl chr 3:4,979,437...4,985,323
JBrowse link
G BMP4 bone morphogenetic protein 4 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of BMP4 mRNA CTD PMID:21127053 NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
JBrowse link
G BRDTP1 bromodomain testis associated pseudogene 1 decreases expression EXP Rifampin results in decreased expression of BRDTP1 mRNA CTD PMID:24552687 NCBI chr  X:96,337,086...96,337,902
Ensembl chr  X:96,337,236...96,337,912
JBrowse link
G C4orf51 chromosome 4 open reading frame 51 decreases expression EXP Rifampin results in decreased expression of C4ORF51 mRNA CTD PMID:24552687 NCBI chr 4:145,680,146...145,792,443
Ensembl chr 4:145,680,146...145,771,032
JBrowse link
G C9orf153 chromosome 9 open reading frame 153 decreases expression EXP Rifampin results in decreased expression of C9ORF153 mRNA CTD PMID:24552687 NCBI chr 9:86,220,265...86,259,657
Ensembl chr 9:86,220,265...86,259,657
JBrowse link
G CA1 carbonic anhydrase 1 decreases expression EXP Rifampin results in decreased expression of CA1 mRNA CTD PMID:24552687 NCBI chr 8:85,327,608...85,378,113
Ensembl chr 8:85,327,608...85,379,014
JBrowse link
G CASP1 caspase 1 multiple interactions ISO Rifampin inhibits the reaction [Rotenone results in increased cleavage of CASP1 protein] CTD PMID:26086368 NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
JBrowse link
G CASP3 caspase 3 multiple interactions EXP
ISO
Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased activity of CASP3 protein]]; Rifampin inhibits the reaction [[Acetaminophen co-treated with [ferric nitrate results in increased abundance of Iron]] results in increased cleavage of CASP3 protein]; Rifampin inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; Rifampin inhibits the reaction [FAS protein results in increased activity of CASP3 protein]; Rifampin inhibits the reaction [Staurosporine results in increased cleavage of CASP3 protein]; Rifampin promotes the reaction [Galactosamine results in increased activity of CASP3 protein]
[Isoniazid co-treated with Rifampin] results in increased activity of CASP3 protein; HGF protein inhibits the reaction [[Isoniazid co-treated with Rifampin] results in increased activity of CASP3 protein]; Ursodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in increased activity of CASP3 protein]
CTD PMID:11958592 PMID:12645856 PMID:17936189 PMID:21419764 PMID:23764483 More... NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
JBrowse link
G CASP8 caspase 8 multiple interactions EXP Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased activity of CASP8 protein]]; Rifampin inhibits the reaction [FAS protein results in increased activity of CASP8 protein] CTD PMID:11958592 PMID:12645856 NCBI chr 2:201,233,443...201,287,711
Ensembl chr 2:201,233,443...201,361,836
JBrowse link
G CBR3 carbonyl reductase 3 multiple interactions ISO [Rifampin co-treated with Cobicistat] results in increased expression of CBR3 mRNA CTD PMID:33629115 NCBI chr21:36,135,079...36,146,562
Ensembl chr21:36,135,079...36,146,562
JBrowse link
G CCL2 C-C motif chemokine ligand 2 decreases expression ISO Rifampin results in decreased expression of CCL2 mRNA CTD PMID:25051504 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
JBrowse link
G CCL5 C-C motif chemokine ligand 5 decreases expression ISO Rifampin results in decreased expression of CCL5 protein CTD PMID:25051504 NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
JBrowse link
G CCN1 cellular communication network factor 1 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of CCN1 mRNA CTD PMID:21127053 NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
JBrowse link
G CCND1 cyclin D1 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CCND1 mRNA CTD PMID:21224054 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
JBrowse link
G CCNG1 cyclin G1 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CCNG1 mRNA CTD PMID:21224054 NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,446,151
JBrowse link
G CCR6 C-C motif chemokine receptor 6 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of CCR6 mRNA CTD PMID:21127053 NCBI chr 6:167,111,795...167,139,141
Ensembl chr 6:167,111,807...167,139,141
JBrowse link
G CCR7 C-C motif chemokine receptor 7 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of CCR7 mRNA CTD PMID:21127053 NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,553,769...40,565,472
JBrowse link
G CD36 CD36 molecule increases expression ISO Rifampin results in increased expression of CD36 mRNA CTD PMID:27806127 NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CDKN1A mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CDKN1A protein CTD PMID:21224054 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
JBrowse link
G CDKN2B cyclin dependent kinase inhibitor 2B multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of CDKN2B mRNA CTD PMID:21127053 NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
JBrowse link
G CEBPA CCAAT enhancer binding protein alpha multiple interactions ISO [Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of CEBPA mRNA; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPA mRNA]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPA protein] CTD PMID:33412187 NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
JBrowse link
G CEBPB CCAAT enhancer binding protein beta multiple interactions ISO [Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of CEBPB mRNA; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPB mRNA]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPB protein] CTD PMID:33412187 NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668
JBrowse link
G CEBPD CCAAT enhancer binding protein delta multiple interactions ISO [Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of CEBPD mRNA; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPD mRNA] CTD PMID:33412187 NCBI chr 8:47,736,913...47,738,164
Ensembl chr 8:47,736,913...47,738,164
JBrowse link
G CES1 carboxylesterase 1 increases expression EXP Rifampin results in increased expression of CES1 protein CTD PMID:10640517 NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
JBrowse link
G CES2 carboxylesterase 2 increases expression
multiple interactions
EXP Rifampin results in increased expression of CES2 mRNA; Rifampin results in increased expression of CES2 protein
Dichlororibofuranosylbenzimidazole inhibits the reaction [Rifampin results in increased expression of CES2 mRNA]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of CES2 mRNA]
CTD PMID:10640517 PMID:17003103 NCBI chr16:66,934,471...66,945,096
Ensembl chr16:66,934,444...66,945,096
JBrowse link
G CFLAR CASP8 and FADD like apoptosis regulator multiple interactions
increases expression
EXP Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]]; Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]
Rifampin results in increased expression of CFLAR protein
CTD PMID:11958592 PMID:12645856 NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687
JBrowse link
G CHEK2 checkpoint kinase 2 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CHEK2 mRNA CTD PMID:21224054 NCBI chr22:28,687,743...28,741,834
Ensembl chr22:28,687,743...28,742,422
JBrowse link
G CIZ1 CDKN1A interacting zinc finger protein 1 decreases expression EXP Rifampin results in decreased expression of CIZ1 mRNA CTD PMID:24552687 NCBI chr 9:128,166,065...128,204,222
Ensembl chr 9:128,161,251...128,204,383
JBrowse link
G CLK2 CDC like kinase 2 decreases expression EXP Rifampin results in decreased expression of CLK2 mRNA CTD PMID:24552687 NCBI chr 1:155,262,868...155,273,504
Ensembl chr 1:155,262,868...155,278,491
JBrowse link
G CNTLN centlein increases expression EXP Rifampin results in increased expression of CNTLN mRNA CTD PMID:24552687 NCBI chr 9:17,135,040...17,528,634
Ensembl chr 9:17,134,982...17,503,923
JBrowse link
G CPT1A carnitine palmitoyltransferase 1A increases expression ISO Rifampin results in increased expression of CPT1A mRNA CTD PMID:27806127 NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
JBrowse link
G CRHR1 corticotropin releasing hormone receptor 1 decreases expression EXP Rifampin results in decreased expression of CRHR1 mRNA CTD PMID:24552687 NCBI chr17:45,784,320...45,835,828
Ensembl chr17:45,784,280...45,835,828
JBrowse link
G CRP C-reactive protein multiple interactions EXP [Floxacillin co-treated with Gentamicins co-treated with Rifampin] results in increased expression of CRP protein CTD PMID:16943303 NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
JBrowse link
G CSNK1G1 casein kinase 1 gamma 1 decreases expression EXP Rifampin results in decreased expression of CSNK1G1 mRNA CTD PMID:24552687 NCBI chr15:64,165,525...64,356,173
Ensembl chr15:64,165,525...64,356,173
JBrowse link
G CXCL1 C-X-C motif chemokine ligand 1 increases expression ISO Rifampin results in increased expression of CXCL1 protein CTD PMID:25051504 NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
JBrowse link
G CXCL10 C-X-C motif chemokine ligand 10 multiple interactions
affects expression
ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CXCL10 mRNA
Rifampin affects the expression of CXCL10 protein
CTD PMID:21224054 PMID:25051504 NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
JBrowse link
G CYB5RL cytochrome b5 reductase like increases expression EXP Rifampin results in increased expression of CYB5RL mRNA CTD PMID:24552687 NCBI chr 1:54,169,651...54,200,030
Ensembl chr 1:54,169,651...54,200,036
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions
increases activity
increases expression
ISO
EXP
Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]
Rifampin results in increased activity of CYP1A1 protein
Rifampin results in increased expression of CYP1A1 mRNA; Rifampin results in increased expression of CYP1A1 protein
[Methylcholanthrene co-treated with Rifampin co-treated with Phenobarbital] results in increased expression of CYP1A1 mRNA; [Rifampin co-treated with Monocrotophos] results in increased activity of CYP1A1 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP1A1 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP1A1 protein; [Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of CYP1A1 mRNA; Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]
CTD PMID:12040753 PMID:18493746 PMID:19118567 PMID:19409404 PMID:22733800 More... NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 multiple interactions
increases expression
EXP
ISO
[Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of CYP1A2 mRNA; Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]
Rifampin results in increased expression of CYP1A2 mRNA
[[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in decreased expression of CYP1A2 protein
Rifampin results in increased expression of CYP1A2 mRNA; Rifampin results in increased expression of CYP1A2 protein
CTD PMID:15977188 PMID:17590308 PMID:18493746 PMID:25835148 PMID:29162470 More... NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
JBrowse link
G CYP1B1 cytochrome P450 family 1 subfamily B member 1 multiple interactions ISO
EXP
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP1B1 mRNA
[Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of CYP1B1 mRNA
CTD PMID:21224054 PMID:29162470 NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
JBrowse link
G CYP24A1 cytochrome P450 family 24 subfamily A member 1 multiple interactions
increases expression
increases activity
EXP NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP24A1 mRNA]; Rifampin promotes the reaction [NR1I2 protein binds to CYP24A1 promoter]
Rifampin results in increased activity of CYP24A1 protein
CTD PMID:15630458 PMID:21127053 NCBI chr20:54,143,538...54,173,986
Ensembl chr20:54,153,446...54,173,986
JBrowse link
G CYP26A1 cytochrome P450 family 26 subfamily A member 1 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of CYP26A1 mRNA CTD PMID:21127053 NCBI chr10:93,073,475...93,077,885
Ensembl chr10:93,073,475...93,077,885
JBrowse link
G CYP27A1 cytochrome P450 family 27 subfamily A member 1 multiple interactions
increases expression
EXP Rifampin promotes the reaction [[NR1I2 protein binds to NCOA1 protein] which binds to CYP27A1 gene]
Rifampin results in increased expression of CYP27A1 mRNA
CTD PMID:17088262 NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
JBrowse link
G CYP2A13 cytochrome P450 family 2 subfamily A member 13 decreases expression
increases expression
EXP
ISO
Rifampin results in decreased expression of CYP2A13 mRNA
Rifampin results in increased expression of CYP2A1 mRNA
Rifampin results in increased expression of CYP2A13 mRNA
CTD PMID:19118567 PMID:22258563 NCBI chr19:41,088,451...41,096,195
Ensembl chr19:41,088,451...41,096,195
JBrowse link
G CYP2A6 cytochrome P450 family 2 subfamily A member 6 multiple interactions
increases activity
increases expression
EXP
ISO
[Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of CYP2A6 mRNA; Rifampin promotes the reaction [NR1I2 protein binds to CYP2A6 promoter]; Rifampin promotes the reaction [PPARGC1A protein binds to CYP2A6 promoter]
Rifampin results in increased activity of CYP2A5 protein
Rifampin results in increased expression of CYP2A5 mRNA
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP2A5 mRNA
Rifampin results in increased expression of CYP2A6 mRNA; Rifampin results in increased expression of CYP2A6 protein
CTD PMID:11038160 PMID:14709624 PMID:15629111 PMID:16857725 PMID:19118567 More... NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
JBrowse link
G CYP2A7 cytochrome P450 family 2 subfamily A member 7 increases expression ISO Rifampin results in increased expression of CYP2A4 mRNA CTD PMID:30503582 NCBI chr19:40,875,439...40,882,231
Ensembl chr19:40,875,439...40,882,752
JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 multiple interactions
increases expression
increases activity
ISO
EXP
[[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in increased expression of CYP2B10 protein; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP2B10 mRNA
Rifampin results in increased expression of CYP2B10 mRNA
Rifampin results in increased expression of CYP2B6 mRNA; Rifampin results in increased expression of CYP2B6 protein
[Rifampin co-treated with Monocrotophos] results in increased activity of CYP2B6 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP2B6 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP2B6 protein; [Rifampin co-treated with NR1I2 protein] results in increased expression of CYP2B6 mRNA; [Rifampin results in increased activity of NR1I2 protein] which results in increased expression of CYP2B6 mRNA; Camptothecin inhibits the reaction [Rifampin results in increased expression of CYP2B6 mRNA]; Dexamethasone promotes the reaction [NR3C1 protein affects the reaction [NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP2B6 mRNA]]]; Dexamethasone promotes the reaction [Rifampin results in increased expression of CYP2B6 mRNA]; GW 3965 inhibits the reaction [Rifampin results in increased expression of CYP2B6 mRNA]; Ketoconazole inhibits the reaction [Rifampin results in increased expression of CYP2B6 mRNA]; NR1I2 mRNA promotes the reaction [Rifampin results in increased expression of CYP2B6 mRNA]; NR1I2 protein affects the reaction [Rifampin results in increased expression of and results in increased activity of CYP2B6 protein]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP2B6 mRNA]; Rifampin results in increased expression of and results in increased activity of CYP2B6 protein
Rifampin results in increased activity of CYP2B6 protein
CTD PMID:12040753 PMID:12571232 PMID:12695351 PMID:14709624 PMID:14977870 More... NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
JBrowse link
G CYP2C18 cytochrome P450 family 2 subfamily C member 18 decreases expression EXP Rifampin results in decreased expression of CYP2C18 mRNA; Rifampin results in decreased expression of CYP2C18 protein CTD PMID:22258563 PMID:31629065 NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190
JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 multiple interactions
increases activity
increases expression
EXP Rifampin results in increased expression of and results in increased activity of CYP2C19 protein
Rifampin results in increased activity of CYP2C19 protein
Rifampin results in increased expression of CYP2C19 mRNA; Rifampin results in increased expression of CYP2C19 protein
CTD PMID:12584154 PMID:14709624 PMID:15629111 PMID:17954527 PMID:19118567 More... NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
JBrowse link
G CYP2C8 cytochrome P450 family 2 subfamily C member 8 affects binding
increases expression
multiple interactions
increases activity
EXP
ISO
[Rifampin binds to NR1I2 protein] which binds to CYP2C8 promoter
Rifampin results in increased expression of CYP2C29 mRNA
[Rifampin inhibits the reaction [CYP2C8 protein results in increased susceptibility to Amodiaquine]] which results in decreased expression of BCL2 protein; [Rifampin inhibits the reaction [CYP2C8 protein results in increased susceptibility to Amodiaquine]] which results in decreased expression of MCL1 protein; [Rifampin inhibits the reaction [CYP2C8 protein results in increased susceptibility to Amodiaquine]] which results in increased expression of BAX protein; Camptothecin inhibits the reaction [Rifampin results in increased expression of CYP2C8 mRNA]; pimecrolimus inhibits the reaction [Rifampin results in increased expression of CYP2C8 mRNA]; Rifampin inhibits the reaction [CYP2C8 protein results in increased susceptibility to Amodiaquine]
[[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in increased expression of CYP2C protein
Rifampin results in increased expression of CYP2C8 mRNA; Rifampin results in increased expression of CYP2C8 protein
Rifampin results in increased activity of CYP2C8 protein
CTD PMID:12040753 PMID:15771232 PMID:15933212 PMID:17954527 PMID:19118567 More... NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 multiple interactions
increases activity
increases expression
EXP Ketoconazole inhibits the reaction [Rifampin results in increased expression of CYP2C9 mRNA]; NCOA6 promotes the reaction [Rifampin promotes the reaction [[HNF4A co-treated with NR1I2] results in increased expression of CYP2C9 mRNA]]; NR1I2 protein affects the reaction [Rifampin results in increased expression of CYP2C9 mRNA]; Rifampin promotes the reaction [[HNF4A co-treated with NCOA6] results in increased expression of CYP2C9 mRNA]; Rifampin promotes the reaction [[HNF4A co-treated with NR1I2] results in increased expression of CYP2C9 mRNA]; Rifampin promotes the reaction [NR1I2 protein results in increased expression of CYP2C9 mRNA]; Rifampin results in increased activity of and results in increased expression of CYP2C9 protein; Rifampin results in increased expression of and results in increased activity of CYP2C9 protein
Rifampin results in increased activity of CYP2C9 protein
Rifampin results in increased expression of CYP2C9 mRNA; Rifampin results in increased expression of CYP2C9 protein
CTD PMID:14600250 PMID:14709624 PMID:14722322 PMID:15629111 PMID:15802389 More... NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 increases expression
decreases expression
EXP
ISO
Rifampin results in increased expression of CYP2D6 mRNA
Rifampin results in decreased expression of CYP2D22 mRNA
CTD PMID:19041851 PMID:30503582 PMID:33844597 NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 increases activity
decreases expression
multiple interactions
increases expression
EXP
ISO
Rifampin results in increased activity of CYP2E1 protein
Rifampin results in decreased expression of CYP2E1 mRNA
[[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in decreased expression of CYP2E1 protein
Rifampin results in increased expression of CYP2E1 mRNA; Rifampin results in increased expression of CYP2E1 protein
[Rifampin co-treated with Monocrotophos] results in increased activity of CYP2E1 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP2E1 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP2E1 protein
[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased activity of CYP2E1 protein; [Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP2E1 mRNA; [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased activity of CYP2E1 protein]; [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP2E1 mRNA]; Methionine inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased activity of CYP2E1 protein]; Methionine inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP2E1 mRNA]; Rifampin inhibits the reaction [Isoniazid results in increased expression of CYP2E1 protein]
CTD PMID:15132840 PMID:18071298 PMID:22258563 PMID:22733800 PMID:25835148 More... NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
JBrowse link
G CYP2F1 cytochrome P450 family 2 subfamily F member 1 decreases expression EXP Rifampin results in decreased expression of CYP2F1 mRNA CTD PMID:22258563 NCBI chr19:41,114,432...41,128,381
Ensembl chr19:41,114,432...41,128,381
JBrowse link
G CYP2J2 cytochrome P450 family 2 subfamily J member 2 decreases expression EXP Rifampin results in decreased expression of CYP2J2 mRNA CTD PMID:33263786 NCBI chr 1:59,893,308...59,969,212
Ensembl chr 1:59,893,308...59,926,773
JBrowse link
G CYP2S1 cytochrome P450 family 2 subfamily S member 1 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of CYP2S1 mRNA CTD PMID:21127053 NCBI chr19:41,193,219...41,207,539
Ensembl chr19:41,193,210...41,207,539
JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 affects activity
increases expression
multiple interactions
decreases response to substance
increases activity
EXP
ISO
Rifampin affects the activity of CYP3A4 protein
Rifampin results in increased expression of CYP3A2 mRNA; Rifampin results in increased expression of CYP3A4 mRNA
[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP3A2 mRNA; [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP3A2 mRNA]; arsenite inhibits the reaction [Rifampin results in increased expression of and results in increased activity of CYP3A2 protein]; arsenite inhibits the reaction [Rifampin results in increased expression of CYP3A2 mRNA]; Methionine inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP3A2 mRNA]; Rifampin results in increased expression of and results in increased activity of CYP3A2 protein
CYP3A4 protein results in decreased susceptibility to Rifampin
[[Rifampin results in increased activity of NR1I2 protein] which results in increased activity of CYP3A4 protein] which results in increased metabolism of and results in increased activity of and results in increased susceptibility to Cobicistat; [Dimethyl Sulfoxide results in increased susceptibility to Rifampin] which results in increased expression of CYP3A4 mRNA; [HNF4A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA; [Methylcholanthrene co-treated with Rifampin co-treated with Phenobarbital] results in increased expression of CYP3A4 mRNA; [NR1I2 protein binds to NCOR2 protein] inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; [NR1I2 protein co-treated with Rifampin] results in decreased expression of CYP3A4 mRNA; [PPARGC1A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA; [Rifampin binds to and results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; [Rifampin binds to CYP3A4 promoter] which results in increased expression of CYP3A4 mRNA; [Rifampin co-treated with Monocrotophos] results in increased activity of CYP3A4 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP3A4 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP3A4 protein; [Rifampin co-treated with NR1I2 protein] results in increased expression of CYP3A4 mRNA; [Rifampin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; [Rifampin results in increased expression of CYP3A4 protein] which results in decreased abundance of Ethinyl Estradiol; [Rifampin results in increased expression of CYP3A4 protein] which results in decreased abundance of Midazolam; [Rifampin results in increased expression of CYP3A4 protein] which results in increased hydroxylation of Testosterone; [Rifampin results in increased expression of NR1I2 protein] which results in increased expression of and results in increased activity of CYP3A4 protein; [RXRA protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA; [SRC protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA; [Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of CYP3A4 mRNA; AADAC mRNA affects the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; allyl isothiocyanate inhibits the reaction [[HNF4A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; allyl isothiocyanate inhibits the reaction [[PPARGC1A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; allyl isothiocyanate inhibits the reaction [[RXRA protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; allyl isothiocyanate inhibits the reaction [[SRC protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [[HNF4A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]]; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [[PPARGC1A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]]; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [[RXRA protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]]; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [[SRC protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]]; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]]; allyl isothiocyanate inhibits the reaction [Rifampin results in increased activity of CYP3A4 protein]; allyl isothiocyanate inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; allyl isothiocyanate inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein]; Arsenic Trioxide inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein]; Calcitriol promotes the reaction [Rifampin results in increased activity of CYP3A4 protein]; Calcitriol promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Camptothecin inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; CYP3A4 protein inhibits the reaction [Rifampin results in decreased chemical synthesis of 1-hydroxymethylmidazolam]; CYP3A4 protein inhibits the reaction [Rifampin results in decreased chemical synthesis of 4-hydroxymidazolam]; CYP3A4 protein inhibits the reaction [Rifampin results in decreased hydroxylation of Midazolam]; Dexamethasone promotes the reaction [Rifampin results in increased activity of CYP3A4 protein]; Dichlororibofuranosylbenzimidazole inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Dimethyl Sulfoxide promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Econazole promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Galactosamine inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; GW 3965 inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Ketoconazole inhibits the reaction [NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]]; Ketoconazole inhibits the reaction [NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP3A4 protein]]; Ketoconazole inhibits the reaction [Rifampin promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]; Ketoconazole inhibits the reaction [Rifampin results in increased activity of CYP3A4 protein]; Ketoconazole inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Ketoconazole inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein]; lorlatinib inhibits the reaction [Rifampin results in increased activity of CYP3A4 protein]; Metformin inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Metformin inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein]; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Rifampin promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]; NR1H3 mutant form inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; NR1I2 gene promotes the reaction [Rifampin results in increased expression of CYP3A4 protein]; NR1I2 mRNA promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; NR1I2 protein affects the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; NR1I2 protein affects the reaction [Rifampin results in increased expression of CYP3A4 protein]; NR1I2 protein inhibits the reaction [Thapsigargin inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]]; NR1I2 protein promotes the reaction [[HNF4A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [[PPARGC1A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [[RXRA protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [[SRC protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP3A4 protein]; NR3C1 protein promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; ochratoxin A inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; ochratoxin A inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein]; oxiconazole inhibits the reaction [Rifampin promotes the reaction [NR1I2 results in increased expression of CYP3A4 mRNA]]; periodate-oxidized adenosine inhibits the reaction [Dimethyl Sulfoxide promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]]; PRMT1 protein affects the reaction [[Dimethyl Sulfoxide results in increased susceptibility to Rifampin] which results in increased expression of CYP3A4 mRNA]; PRMT1 protein affects the reaction [Dimethyl Sulfoxide promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]]; PRMT1 protein affects the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Rifampin binds to and results in increased activity of CYP3A4 protein; Rifampin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Rifampin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam]; Rifampin inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam]; Rifampin promotes the reaction [[HNF4A co-treated with NCOA6] results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [[HNF4A co-treated with NR1I2] results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [[NCOA1 protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [Calcitriol results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Rifampin promotes the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam]; Rifampin promotes the reaction [CYP3A4 protein results in increased metabolism of Lidocaine]; Rifampin promotes the reaction [NR1I2 protein binds to CYP3A4 promoter]; Rifampin promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [NR1I2 results in increased expression of CYP3A4 mRNA]; Rifampin results in increased expression of and results in increased activity of CYP3A4 protein; Skatole inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Skatole inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein]; sodium arsenite inhibits the reaction [Rifampin results in increased expression of and results in increased activity of CYP3A4 protein]; sodium arsenite inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; sulforaphane inhibits the reaction [Rifampin results in increased expression of CYP3A4]; Tetrachlorodibenzodioxin inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein]; Thapsigargin inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; trichostatin A affects the reaction [Dimethyl Sulfoxide promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]]; trichostatin A promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]
[Rifampin results in increased activity of NR1I2 protein] which results in increased activity of CYP3A4 protein; Rifampin results in increased activity of CYP3A4 protein
Rifampin results in increased expression of CYP3A4; Rifampin results in increased expression of CYP3A4 mRNA; Rifampin results in increased expression of CYP3A4 mRNA alternative form; Rifampin results in increased expression of CYP3A4 protein
CTD PMID:8632764 PMID:9298257 PMID:9512926 PMID:10219967 PMID:10640517 More... NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G CYP3A5 cytochrome P450 family 3 subfamily A member 5 increases expression
multiple interactions
EXP
ISO
Rifampin results in increased expression of CYP3A5 mRNA
Rifampin results in increased expression of CYP3A11 mRNA; Rifampin results in increased expression of CYP3A11 protein
[[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in increased expression of CYP3A11 protein; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP3A11 mRNA; [Rifampin binds to NR1I2 gene mutant form] which results in increased expression of CYP3A11 mRNA; sulforaphane inhibits the reaction [Rifampin results in increased expression of CYP3A11 mRNA]
CTD PMID:12040753 PMID:12673034 PMID:15629111 PMID:15681896 PMID:19118567 More... NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,998
JBrowse link
G CYP3A7 cytochrome P450 family 3 subfamily A member 7 increases expression EXP Rifampin results in increased expression of CYP3A7 mRNA CTD PMID:12673034 PMID:19118567 PMID:22258563 PMID:24146111 PMID:24552687 More... NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196
JBrowse link
G CYP7A1 cytochrome P450 family 7 subfamily A member 1 multiple interactions
decreases expression
ISO
EXP
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP7A1 mRNA
Rifampin results in decreased expression of CYP7A1 mRNA
NR1I2 protein promotes the reaction [Rifampin results in decreased expression of CYP7A1 mRNA]
CTD PMID:15629111 PMID:21127053 PMID:21224054 PMID:22258563 PMID:24259679 More... NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
JBrowse link
G CYP8B1 cytochrome P450 family 8 subfamily B member 1 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in decreased expression of CYP8B1 mRNA CTD PMID:21127053 NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
JBrowse link
G DCAF5 DDB1 and CUL4 associated factor 5 decreases expression EXP Rifampin results in decreased expression of DCAF5 mRNA CTD PMID:24552687 NCBI chr14:69,050,881...69,153,197
Ensembl chr14:69,050,881...69,153,150
JBrowse link
G DCLRE1B DNA cross-link repair 1B decreases expression EXP Rifampin results in decreased expression of DCLRE1B mRNA CTD PMID:24552687 NCBI chr 1:113,904,619...113,914,086
Ensembl chr 1:113,905,213...113,914,086
JBrowse link
G DDIT3 DNA damage inducible transcript 3 multiple interactions
increases expression
ISO
EXP
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of DDIT3 mRNA; [Rifampin co-treated with Cobicistat] results in increased expression of DDIT3 mRNA
4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of DDIT3 mRNA]
Rifampin results in increased expression of DDIT3 mRNA; Rifampin results in increased expression of DDIT3 protein
CTD PMID:21224054 PMID:27470132 PMID:32535746 PMID:33629115 NCBI chr12:57,516,588...57,521,698
Ensembl chr12:57,516,588...57,521,737
JBrowse link
G DHCR24 24-dehydrocholesterol reductase multiple interactions EXP [Rifampin results in increased activity of NR1I2 protein] which results in increased expression of DHCR24 mRNA CTD PMID:22101211 NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195
JBrowse link
G DIO1 iodothyronine deiodinase 1 increases expression EXP Rifampin results in increased expression of DIO1 mRNA CTD PMID:24552687 NCBI chr 1:53,894,187...53,911,086
Ensembl chr 1:53,891,239...53,911,086
JBrowse link
G DLX4 distal-less homeobox 4 decreases expression EXP Rifampin results in decreased expression of DLX4 mRNA CTD PMID:24552687 NCBI chr17:49,968,572...49,974,959
Ensembl chr17:49,968,970...49,974,959
JBrowse link
G DNAJA1 DnaJ heat shock protein family (Hsp40) member A1 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of DNAJA1 mRNA CTD PMID:21224054 NCBI chr 9:33,025,273...33,039,907
Ensembl chr 9:33,025,273...33,039,907
JBrowse link
G E2F1 E2F transcription factor 1 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of E2F1 mRNA CTD PMID:21224054 NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
JBrowse link
G EDN1 endothelin 1 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of EDN1 mRNA CTD PMID:21127053 NCBI chr 6:12,256,484...12,297,194
Ensembl chr 6:12,290,361...12,297,194
JBrowse link
G EGR1 early growth response 1 multiple interactions ISO
EXP
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of EGR1 mRNA
[Rifampin co-treated with NR1I2 protein] results in increased expression of EGR1 mRNA
CTD PMID:21127053 PMID:21224054 NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
JBrowse link
G EGR2 early growth response 2 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of EGR2 mRNA CTD PMID:21127053 NCBI chr10:62,811,996...62,819,167
Ensembl chr10:62,811,996...62,819,167
JBrowse link
G EGR4 early growth response 4 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of EGR4 mRNA CTD PMID:21127053 NCBI chr 2:73,290,929...73,293,548
Ensembl chr 2:73,290,929...73,293,701
JBrowse link
G EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 increases phosphorylation
increases expression
multiple interactions
ISO
EXP
Rifampin results in increased phosphorylation of EIF2AK3 protein
Rifampin results in increased expression of EIF2AK3 mRNA; Rifampin results in increased expression of EIF2AK3 protein
4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of EIF2AK3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of EIF2AK3 protein]
CTD PMID:24638036 PMID:27470132 NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
JBrowse link
G EIF2S1 eukaryotic translation initiation factor 2 subunit alpha increases phosphorylation ISO Rifampin results in increased phosphorylation of EIF2S1 protein CTD PMID:24638036 NCBI chr14:67,360,328...67,386,516
Ensembl chr14:67,360,328...67,386,516
JBrowse link
G ELK1 ETS transcription factor ELK1 decreases expression EXP Rifampin results in decreased expression of ELK1 mRNA CTD PMID:24552687 NCBI chr  X:47,635,520...47,650,604
Ensembl chr  X:47,635,521...47,650,604
JBrowse link
G EPAS1 endothelial PAS domain protein 1 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of EPAS1 mRNA CTD PMID:21127053 NCBI chr 2:46,297,407...46,386,697
Ensembl chr 2:46,293,667...46,386,697
JBrowse link
G EPHA1-AS1 EPHA1 antisense RNA 1 decreases expression EXP Rifampin results in decreased expression of EPHA1-AS1 mRNA CTD PMID:24552687 NCBI chr 7:143,407,813...143,523,449
Ensembl chr 7:143,407,784...143,523,449
JBrowse link
G EPHX1 epoxide hydrolase 1 increases expression
multiple interactions
EXP Rifampin results in increased expression of EPHX1 mRNA
pimecrolimus inhibits the reaction [Rifampin results in increased expression of EPHX1 mRNA]
CTD PMID:22258563 PMID:25313206 PMID:29356861 NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
JBrowse link
G ERN1 endoplasmic reticulum to nucleus signaling 1 multiple interactions
increases expression
EXP Rifampin results in increased expression of and results in increased phosphorylation of ERN1 protein
Rifampin results in increased expression of ERN1 mRNA
CTD PMID:32535746 NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
JBrowse link
G ETNPPL ethanolamine-phosphate phospho-lyase increases expression EXP Rifampin results in increased expression of ETNPPL mRNA CTD PMID:24552687 NCBI chr 4:108,742,053...108,763,053
Ensembl chr 4:108,742,048...108,763,054
JBrowse link
G F13B coagulation factor XIII B chain increases expression EXP Rifampin results in increased expression of F13B mRNA CTD PMID:24552687 NCBI chr 1:197,038,741...197,067,260
Ensembl chr 1:197,038,741...197,067,260
JBrowse link
G FAM200A family with sequence similarity 200 member A increases expression EXP Rifampin results in increased expression of FAM200A mRNA CTD PMID:24552687 NCBI chr 7:99,546,300...99,558,543
Ensembl chr 7:99,546,300...99,558,536
JBrowse link
G FAM230C family with sequence similarity 230 member C decreases expression EXP Rifampin results in decreased expression of FAM230C mRNA CTD PMID:24552687 NCBI chr13:18,195,297...18,232,016
Ensembl chr13:18,195,297...18,232,024
JBrowse link
G FAM66D family with sequence similarity 66 member D decreases expression EXP Rifampin results in decreased expression of FAM66D mRNA CTD PMID:24552687 NCBI chr 8:12,115,782...12,151,189
Ensembl chr 8:12,115,767...12,177,550
JBrowse link
G FAS Fas cell surface death receptor multiple interactions EXP Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased activity of CASP3 protein]]; Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased activity of CASP8 protein]]; Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]]; Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of FASLG protein]]; Rifampin inhibits the reaction [FAS protein results in increased activity of CASP3 protein]; Rifampin inhibits the reaction [FAS protein results in increased activity of CASP8 protein]; Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]; Rifampin inhibits the reaction [FAS protein results in increased expression of FASLG protein] CTD PMID:11958592 PMID:12645856 NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
JBrowse link
G FASLG Fas ligand multiple interactions
decreases expression
ISO
EXP
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FASL mRNA
Rifampin results in decreased expression of FASLG mRNA; Rifampin results in decreased expression of FASLG protein
Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of FASLG protein]]; Rifampin inhibits the reaction [FAS protein results in increased expression of FASLG protein]
CTD PMID:11958592 PMID:12645856 PMID:21224054 PMID:24552687 NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
JBrowse link
G FASN fatty acid synthase increases expression
affects expression
multiple interactions
ISO
EXP
Rifampin results in increased expression of FASN mRNA
Rifampin affects the expression of FASN mRNA
pimecrolimus inhibits the reaction [Rifampin results in increased expression of FASN mRNA]
CTD PMID:27806127 PMID:29356861 PMID:34689256 NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
JBrowse link
G FGF19 fibroblast growth factor 19 multiple interactions
increases expression
EXP [Rifampin binds to and results in increased activity of NR1I2 protein] which results in increased expression of FGF19 mRNA
Rifampin results in increased expression of FGF19 mRNA
CTD PMID:17696253 NCBI chr11:69,698,238...69,704,022
Ensembl chr11:69,698,238...69,704,022
JBrowse link
G FMO1 flavin containing dimethylaniline monoxygenase 1 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO1 mRNA CTD PMID:21224054 NCBI chr 1:171,248,494...171,285,978
Ensembl chr 1:171,248,471...171,285,978
JBrowse link
G FMO4 flavin containing dimethylaniline monoxygenase 4 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO4 mRNA CTD PMID:21224054 NCBI chr 1:171,314,183...171,342,084
Ensembl chr 1:171,314,183...171,342,084
JBrowse link
G FOXA1 forkhead box A1 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in decreased expression of FOXA1 mRNA CTD PMID:21127053 NCBI chr14:37,589,552...37,595,249
Ensembl chr14:37,589,552...37,596,059
JBrowse link
G FOXP1 forkhead box P1 increases expression EXP Rifampin results in increased expression of FOXP1 mRNA CTD PMID:24552687 NCBI chr 3:70,954,708...71,583,978
Ensembl chr 3:70,954,693...71,583,978
JBrowse link
G FUT1 fucosyltransferase 1 (H blood group) decreases expression EXP Rifampin results in decreased expression of FUT1 mRNA CTD PMID:24552687 NCBI chr19:48,748,011...48,755,358
Ensembl chr19:48,748,011...48,755,390
JBrowse link
G G6PC1 glucose-6-phosphatase catalytic subunit 1 multiple interactions
decreases expression
affects expression
EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of G6PC1 mRNA; INS protein inhibits the reaction [[Rifampin co-treated with NR1I2 protein] results in increased expression of G6PC1 mRNA]; SGK2 mutant form affects the reaction [Rifampin affects the expression of G6PC1 mRNA]; SGK2 mutant form inhibits the reaction [[Rifampin co-treated with NR1I2 protein] results in increased expression of G6PC1 mRNA]
Rifampin results in decreased expression of G6PC mRNA
CTD PMID:24204015 PMID:34689256 NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
JBrowse link
G GADD45A growth arrest and DNA damage inducible alpha multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GADD45A mRNA CTD PMID:21224054 NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
JBrowse link
G GADD45B growth arrest and DNA damage inducible beta multiple interactions EXP NR1I2 protein promotes the reaction [Rifampin results in increased expression of GADD45B mRNA] CTD PMID:21127053 NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259
JBrowse link
G GATA5 GATA binding protein 5 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in decreased expression of GATA5 mRNA CTD PMID:21127053 NCBI chr20:62,463,497...62,475,995
Ensembl chr20:62,463,497...62,475,995
JBrowse link
G GCK glucokinase decreases expression
multiple interactions
EXP Rifampin results in decreased expression of GCK protein
NR1I2 protein promotes the reaction [Rifampin results in decreased expression of GCK protein]
CTD PMID:26616219 NCBI chr 7:44,143,213...44,189,439
Ensembl chr 7:44,143,213...44,198,170
JBrowse link
G GCOM1 GCOM1, MYZAP-POLR2M combined locus decreases expression EXP Rifampin results in decreased expression of GCOM1 mRNA CTD PMID:24552687 NCBI chr15:57,591,904...57,717,557
Ensembl chr15:57,591,908...57,714,745
JBrowse link
G GLIS2 GLIS family zinc finger 2 increases expression EXP Rifampin results in increased expression of GLIS2 mRNA CTD PMID:24552687 NCBI chr16:4,314,761...4,339,595
Ensembl chr16:4,314,761...4,339,597
JBrowse link
G GNAL G protein subunit alpha L decreases expression EXP Rifampin results in decreased expression of GNAL mRNA CTD PMID:24552687 NCBI chr18:11,689,264...11,885,685
Ensembl chr18:11,689,264...11,885,685
JBrowse link
G GPT glutamic--pyruvic transaminase multiple interactions
increases expression
EXP
ISO
4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of GPT protein]; [Rifampin co-treated with Acetaminophen] results in decreased activity of GPT protein
Rifampin inhibits the reaction [Acetaminophen results in increased expression of GPT protein]
CTD PMID:24685772 PMID:27470132 PMID:31678598 NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
JBrowse link
G GPX2 glutathione peroxidase 2 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GPX2 mRNA; [Rifampin co-treated with Cobicistat] results in increased expression of GPX2 mRNA CTD PMID:21224054 PMID:33629115 NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
JBrowse link
G GRIA1 glutamate ionotropic receptor AMPA type subunit 1 decreases expression EXP Rifampin results in decreased expression of GRIA1 mRNA CTD PMID:24552687 NCBI chr 5:153,489,615...153,813,869
Ensembl chr 5:153,489,615...153,813,869
JBrowse link
G GSR glutathione-disulfide reductase increases activity ISO Rifampin results in increased activity of GSR protein CTD PMID:20848779 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
JBrowse link
G GSTA1 glutathione S-transferase alpha 1 multiple interactions
increases expression
EXP [Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of GSTA1 mRNA; Ketoconazole inhibits the reaction [Rifampin results in increased expression of GSTA1 mRNA] CTD PMID:16608920 PMID:19118567 PMID:29162470 NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
JBrowse link
G GSTA7P glutathione S-transferase alpha 7, pseudogene increases expression EXP Rifampin results in increased expression of GSTA7P mRNA CTD PMID:24552687 NCBI chr 6:52,739,463...52,745,159
Ensembl chr 6:52,739,590...52,744,656
JBrowse link
G GSTM1 glutathione S-transferase mu 1 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM1 protein CTD PMID:21224054 NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
JBrowse link
G GSTM3 glutathione S-transferase mu 3 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM3 mRNA CTD PMID:21224054 NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
JBrowse link
G GSTP1 glutathione S-transferase pi 1 multiple interactions
increases expression
EXP [Rifampin co-treated with Monocrotophos] results in increased expression of GSTP1 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of GSTP1 protein
Rifampin results in increased expression of GSTP1 mRNA; Rifampin results in increased expression of GSTP1 protein
CTD PMID:22733800 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
JBrowse link
G GSTT1 glutathione S-transferase theta 1 multiple interactions EXP GSTT1 gene polymorphism affects the susceptibility to [Isoniazid co-treated with Rifampin]; GSTT1 gene polymorphism results in increased susceptibility to [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide] CTD PMID:18397238 PMID:20485159
G GTF2IRD2 GTF2I repeat domain containing 2 increases expression EXP Rifampin results in increased expression of GTF2IRD2 mRNA CTD PMID:24552687 NCBI chr 7:74,796,151...74,851,605
Ensembl chr 7:74,796,151...74,851,605
JBrowse link
G GZMB granzyme B increases secretion EXP Rifampin results in increased secretion of GZMB protein CTD PMID:27933861 NCBI chr14:24,630,954...24,634,190
Ensembl chr14:24,630,954...24,634,267
JBrowse link
G HBEGF heparin binding EGF like growth factor multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of HBEGF mRNA CTD PMID:21127053 NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603
JBrowse link
G HDAC3 histone deacetylase 3 multiple interactions EXP Rifampin inhibits the reaction [trichostatin A inhibits the reaction [[PIAS1 co-treated with SUMO3] inhibits the reaction [NCOR2 protein promotes the reaction [NR1I2 protein binds to HDAC3 protein]]]] CTD PMID:26883953 NCBI chr 5:141,620,881...141,636,849
Ensembl chr 5:141,620,876...141,636,849
JBrowse link
G HDAC5 histone deacetylase 5 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in decreased expression of HDAC5 mRNA CTD PMID:21127053 NCBI chr17:44,076,753...44,123,641
Ensembl chr17:44,076,746...44,123,702
JBrowse link
G HEY1 hes related family bHLH transcription factor with YRPW motif 1 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of HEY1 mRNA CTD PMID:21127053 NCBI chr 8:79,764,010...79,767,767
Ensembl chr 8:79,762,371...79,767,857
JBrowse link
G HGF hepatocyte growth factor multiple interactions ISO HGF protein inhibits the reaction [[Isoniazid co-treated with Rifampin] results in increased abundance of Reactive Oxygen Species]; HGF protein inhibits the reaction [[Isoniazid co-treated with Rifampin] results in increased activity of CASP3 protein] CTD PMID:23764483 NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of HIF1A mRNA CTD PMID:21127053 NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
JBrowse link
G HLA-DMA major histocompatibility complex, class II, DM alpha increases expression EXP Rifampin results in increased expression of HLA-DMA mRNA CTD PMID:24552687 NCBI chr 6:32,948,618...32,953,097
Ensembl chr 6:32,948,613...32,969,094
JBrowse link
G HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 affects expression EXP Rifampin affects the expression of HLA-DQB1 mRNA CTD PMID:25811541 NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
JBrowse link
G HLA-DRB6 major histocompatibility complex, class II, DR beta 6 (pseudogene) affects expression EXP Rifampin affects the expression of HLA-DRB6 mRNA CTD PMID:25811541 NCBI chr 6:32,552,713...32,560,002
Ensembl chr 6:32,552,713...32,560,022
JBrowse link
G HLA-G major histocompatibility complex, class I, G affects expression EXP Rifampin affects the expression of HLA-G mRNA CTD PMID:25811541 NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
JBrowse link
G HMGN5 high mobility group nucleosome binding domain 5 increases expression EXP Rifampin results in increased expression of HMGN5 mRNA CTD PMID:24552687 NCBI chr  X:81,113,699...81,201,913
Ensembl chr  X:81,113,699...81,201,913
JBrowse link
G HMOX1 heme oxygenase 1 multiple interactions
increases expression
ISO
EXP
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HMOX1 mRNA
dorsomorphin inhibits the reaction [Rifampin results in increased expression of HMOX1 protein]
Rifampin results in increased expression of HMOX1 mRNA; Rifampin results in increased expression of HMOX1 protein
[arsenite co-treated with Rifampin] results in increased expression of HMOX1 mRNA
CTD PMID:21224054 PMID:22159698 PMID:22258563 PMID:31678598 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G HNF4A hepatocyte nuclear factor 4 alpha multiple interactions EXP [HNF4A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA; [Rifampin co-treated with NR1I2 protein] results in decreased expression of HNF4A mRNA; [Rifampin results in increased activity of NR1I2 protein] inhibits the reaction [HNF4A protein binds to SULT1E1 enhancer]; allyl isothiocyanate inhibits the reaction [[HNF4A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [[HNF4A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]]; NCOA6 promotes the reaction [Rifampin promotes the reaction [[HNF4A co-treated with NR1I2] results in increased expression of CYP2C9 mRNA]]; NR1I2 protein promotes the reaction [[HNF4A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; Rifampin inhibits the reaction [HNF4A protein binds to SULT1E1 enhancer]; Rifampin promotes the reaction [[HNF4A co-treated with NCOA6] results in increased expression of CYP2C9 mRNA]; Rifampin promotes the reaction [[HNF4A co-treated with NCOA6] results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [[HNF4A co-treated with NR1I2] results in increased expression of CYP2C9 mRNA]; Rifampin promotes the reaction [[HNF4A co-treated with NR1I2] results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [MED1 protein binds to HNF4A protein]; Rifampin promotes the reaction [NCOA1 protein binds to HNF4A protein]; Rifampin promotes the reaction [NCOA2 protein binds to HNF4A protein]; Rifampin promotes the reaction [NCOA6 protein binds to HNF4A protein]; Rifampin promotes the reaction [NR1I2 protein binds to HNF4A protein]; Rifampin promotes the reaction [PPARGC1A protein binds to HNF4A protein] CTD PMID:21127053 PMID:21292004 PMID:21764778 PMID:25069801 NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,700...44,432,845
JBrowse link
G HRH1 histamine receptor H1 increases expression EXP Rifampin results in increased expression of HRH1 mRNA CTD PMID:24552687 NCBI chr 3:11,137,238...11,263,557
Ensembl chr 3:11,137,093...11,263,557
JBrowse link
G HSPA1L heat shock protein family A (Hsp70) member 1 like multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA1L mRNA CTD PMID:21224054 NCBI chr 6:31,809,619...31,815,283
Ensembl chr 6:31,809,619...31,815,283
JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 multiple interactions
increases expression
ISO
EXP
ATF4 mutant form inhibits the reaction [Rifampin results in increased expression of HSPA5 protein]
[Rifampin co-treated with Cobicistat] results in increased expression of HSPA5 mRNA
Rifampin results in increased expression of HSPA5 mRNA; Rifampin results in increased expression of HSPA5 protein
4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of HSPA5 protein]
CTD PMID:24638036 PMID:27470132 PMID:32535746 PMID:33629115 NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
JBrowse link
G HSPA8 heat shock protein family A (Hsp70) member 8 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA8 mRNA CTD PMID:21224054 NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
JBrowse link
G HSPB1 heat shock protein family B (small) member 1 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPB1 mRNA CTD PMID:21224054 NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295
JBrowse link
G HSPD1 heat shock protein family D (Hsp60) member 1 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of HSPD1 mRNA CTD PMID:21224054 NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
JBrowse link
G HSPE1 heat shock protein family E (Hsp10) member 1 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of HSPE1 mRNA CTD PMID:21224054 NCBI chr 2:197,500,379...197,503,449
Ensembl chr 2:197,500,140...197,503,449
JBrowse link
G IFNG interferon gamma increases secretion EXP Rifampin results in increased secretion of IFNG protein CTD PMID:27933861 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
JBrowse link
G IGFBP1 insulin like growth factor binding protein 1 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of IGFBP1 mRNA CTD PMID:21127053 NCBI chr 7:45,888,488...45,893,660
Ensembl chr 7:45,888,360...45,893,660
JBrowse link
G IGFBP3 insulin like growth factor binding protein 3 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of IGFBP3 mRNA CTD PMID:21127053 NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
JBrowse link
G IGFBP4 insulin like growth factor binding protein 4 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of IGFBP4 mRNA CTD PMID:21127053 NCBI chr17:40,443,450...40,457,725
Ensembl chr17:40,443,450...40,457,725
JBrowse link
G IL10 interleukin 10 affects expression ISO Rifampin affects the expression of IL10 protein CTD PMID:25051504 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
JBrowse link
G IL12RB2 interleukin 12 receptor subunit beta 2 decreases expression EXP Rifampin results in decreased expression of IL12RB2 mRNA CTD PMID:24552687 NCBI chr 1:67,307,364...67,398,724
Ensembl chr 1:67,307,364...67,398,724
JBrowse link
G IL13 interleukin 13 increases secretion EXP Rifampin results in increased secretion of IL13 protein CTD PMID:27933861 NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
JBrowse link
G IL18 interleukin 18 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of IL18 mRNA CTD PMID:21224054 NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
JBrowse link
G IL1B interleukin 1 beta multiple interactions
decreases expression
ISO
EXP
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of IL1B mRNA; Rifampin inhibits the reaction [Rotenone results in increased expression of and results in increased secretion of IL1B protein]; Rifampin inhibits the reaction [Rotenone results in increased expression of IL1B mRNA]
Chloroquine inhibits the reaction [Rifampin inhibits the reaction [Rotenone results in increased expression of IL1B mRNA]]; Rifampin inhibits the reaction [Rotenone results in increased expression of IL1B mRNA]
Rifampin results in decreased expression of IL1B mRNA; Rifampin results in decreased expression of IL1B protein
CTD PMID:21224054 PMID:25051504 PMID:26086368 PMID:31648047 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G IL37 interleukin 37 increases expression EXP Rifampin results in increased expression of IL37 mRNA CTD PMID:24552687 NCBI chr 2:112,911,165...112,918,882
Ensembl chr 2:112,911,165...112,918,882
JBrowse link
G IL6 interleukin 6 decreases expression
multiple interactions
increases expression
EXP
ISO
Rifampin results in decreased expression of IL6 protein
Chloroquine inhibits the reaction [Rifampin inhibits the reaction [Rotenone results in increased expression of IL6 mRNA]]; Rifampin inhibits the reaction [Rotenone results in increased expression of IL6 mRNA]
Rifampin results in increased expression of IL6 protein
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of IL6 mRNA
CTD PMID:21224054 PMID:21357946 PMID:25051504 PMID:31648047 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G INO80D INO80 complex subunit D decreases expression EXP Rifampin results in decreased expression of INO80D mRNA CTD PMID:24552687 NCBI chr 2:205,993,721...206,086,174
Ensembl chr 2:205,993,721...206,086,303
JBrowse link
G INS insulin multiple interactions EXP
ISO
INS protein inhibits the reaction [[Rifampin co-treated with NR1I2 protein] results in increased expression of G6PC1 mRNA]
Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPA mRNA]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPA protein]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPB mRNA]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPB protein]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPD mRNA]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA alternative form]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG protein]
CTD PMID:24204015 PMID:33412187 NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
JBrowse link
G INTS6 integrator complex subunit 6 decreases expression EXP Rifampin results in decreased expression of INTS6 mRNA CTD PMID:24552687 NCBI chr13:51,334,405...51,453,036
Ensembl chr13:51,354,077...51,454,264
JBrowse link
G IQCA1 IQ motif containing with AAA domain 1 decreases expression EXP Rifampin results in decreased expression of IQCA1 mRNA CTD PMID:24552687 NCBI chr 2:236,306,685...236,507,476
Ensembl chr 2:236,324,147...236,507,535
JBrowse link
G ITGBL1 integrin subunit beta like 1 decreases expression EXP Rifampin results in decreased expression of ITGBL1 mRNA CTD PMID:24552687 NCBI chr13:101,452,675...101,723,106
Ensembl chr13:101,452,593...101,720,856
JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of JUN mRNA CTD PMID:21127053 NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
JBrowse link
G KIRREL3 kirre like nephrin family adhesion molecule 3 decreases expression EXP Rifampin results in decreased expression of KIRREL3 mRNA CTD PMID:24552687 NCBI chr11:126,423,358...127,000,870
Ensembl chr11:126,423,358...127,003,460
JBrowse link
G KLF2 Kruppel like factor 2 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of KLF2 mRNA CTD PMID:21127053 NCBI chr19:16,324,826...16,328,685
Ensembl chr19:16,324,826...16,328,685
JBrowse link
G KLF5 Kruppel like factor 5 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of KLF5 mRNA CTD PMID:21127053 NCBI chr13:73,054,976...73,077,538
Ensembl chr13:73,054,976...73,077,541
JBrowse link
G KLF6 Kruppel like factor 6 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of KLF6 mRNA CTD PMID:21127053 NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281
JBrowse link
G KLHL23 kelch like family member 23 decreases expression EXP Rifampin results in decreased expression of KLHL23 mRNA CTD PMID:24552687 NCBI chr 2:169,733,832...169,751,878
Ensembl chr 2:169,694,488...169,776,989
JBrowse link
G LDLR low density lipoprotein receptor increases expression ISO Rifampin results in increased expression of LDLR mRNA CTD PMID:27806127 NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,462...11,133,820
JBrowse link
G LEFTY1 left-right determination factor 1 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of LEFTY1 mRNA CTD PMID:21127053 NCBI chr 1:225,886,282...225,889,146
Ensembl chr 1:225,886,282...225,911,382
JBrowse link
G LEP leptin increases expression ISO Rifampin results in increased expression of LEP protein CTD PMID:25051504 NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
JBrowse link
G LIMS3 LIM zinc finger domain containing 3 decreases expression EXP Rifampin results in decreased expression of LIMS3 mRNA CTD PMID:24552687 NCBI chr 2:109,898,688...109,925,625
Ensembl chr 2:109,898,428...109,925,625
JBrowse link
G LINC02898 long intergenic non-protein coding RNA 2898 decreases expression EXP Rifampin results in decreased expression of LINC02898 mRNA CTD PMID:24552687 NCBI chr 2:41,935,368...41,953,806
Ensembl chr 2:41,935,368...41,956,806
JBrowse link
G LL22NC03-63E9.3 uncharacterized LOC648691 increases expression EXP Rifampin results in increased expression of LL22NC03-63E9.3 mRNA CTD PMID:24552687 NCBI chr22:22,559,343...22,566,599
Ensembl chr22:22,559,343...22,566,602
JBrowse link
G LTK leukocyte receptor tyrosine kinase increases expression EXP Rifampin results in increased expression of LTK mRNA CTD PMID:24552687 NCBI chr15:41,503,637...41,513,827
Ensembl chr15:41,503,637...41,513,887
JBrowse link
G MAFF MAF bZIP transcription factor F multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of MAFF mRNA CTD PMID:21127053 NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
JBrowse link
G MAP1LC3B microtubule associated protein 1 light chain 3 beta decreases metabolic processing
increases lipidation
multiple interactions
EXP Rifampin results in decreased metabolism of MAP1LC3B protein
Rifampin results in increased lipidation of MAP1LC3B protein
ATP6V0D1 protein affects the reaction [Rifampin inhibits the reaction [Rotenone results in increased lipidation of MAP1LC3B protein]]; Chloroquine promotes the reaction [Rifampin results in increased lipidation of MAP1LC3B protein]; Rifampin inhibits the reaction [Rotenone results in increased lipidation of MAP1LC3B protein]
CTD PMID:29908302 PMID:31648047 NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
JBrowse link
G MAPK8 mitogen-activated protein kinase 8 multiple interactions EXP Chloroquine inhibits the reaction [Rifampin inhibits the reaction [Rotenone results in increased phosphorylation of MAPK8 protein]]; Rifampin inhibits the reaction [Rotenone results in increased phosphorylation of MAPK8 protein] CTD PMID:31648047 NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
JBrowse link
G MAPKAPK2 MAPK activated protein kinase 2 increases phosphorylation EXP Rifampin results in increased phosphorylation of MAPKAPK2 protein CTD PMID:21127053 NCBI chr 1:206,684,905...206,734,281
Ensembl chr 1:206,684,905...206,734,281
JBrowse link
G MAPRE3 microtubule associated protein RP/EB family member 3 increases expression EXP Rifampin results in increased expression of MAPRE3 mRNA CTD PMID:24552687 NCBI chr 2:26,970,637...27,027,219
Ensembl chr 2:26,970,637...27,027,219
JBrowse link
G MATN2 matrilin 2 increases expression EXP Rifampin results in increased expression of MATN2 mRNA CTD PMID:27177772 NCBI chr 8:97,869,064...98,036,724
Ensembl chr 8:97,868,840...98,036,724
JBrowse link
G MBP myelin basic protein affects expression ISO Rifampin affects the expression of MBP mRNA CTD PMID:22954530 NCBI chr18:76,978,833...77,133,708
Ensembl chr18:76,978,827...77,133,683
JBrowse link
G MCL1 MCL1 apoptosis regulator, BCL2 family member multiple interactions EXP [Rifampin inhibits the reaction [CYP2C8 protein results in increased susceptibility to Amodiaquine]] which results in decreased expression of MCL1 protein CTD PMID:31629065 NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
JBrowse link
G MDM2 MDM2 proto-oncogene multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of MDM2 mRNA CTD PMID:21224054 NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
JBrowse link
G MED1 mediator complex subunit 1 multiple interactions
decreases expression
EXP Rifampin promotes the reaction [MED1 protein binds to and results in increased activity of NR1I2 protein]; Rifampin promotes the reaction [MED1 protein binds to HNF4A protein]
Rifampin results in decreased expression of MED1 mRNA
CTD PMID:21292004 PMID:22214767 PMID:24552687 NCBI chr17:39,404,285...39,451,263
Ensembl chr17:39,404,285...39,451,272
JBrowse link
G MINPP1 multiple inositol-polyphosphate phosphatase 1 increases expression EXP Rifampin results in increased expression of MINPP1 mRNA CTD PMID:24552687 NCBI chr10:87,504,893...87,553,461
Ensembl chr10:87,504,875...87,553,461
JBrowse link
G MIR143 microRNA 143 increases expression EXP Rifampin results in increased expression of MIR143 mRNA CTD PMID:24552687 NCBI chr 5:149,428,918...149,429,023
Ensembl chr 5:149,428,918...149,429,023
JBrowse link
G MIR145 microRNA 145 increases expression EXP Rifampin results in increased expression of MIR145 mRNA CTD PMID:24552687 NCBI chr 5:149,430,646...149,430,733
Ensembl chr 5:149,430,646...149,430,733
JBrowse link
G MIR148B microRNA 148b decreases expression EXP Rifampin results in decreased expression of MIR148B mRNA CTD PMID:24552687 NCBI chr12:54,337,216...54,337,314
Ensembl chr12:54,337,216...54,337,314
JBrowse link
G MIR149 microRNA 149 decreases expression EXP Rifampin results in decreased expression of MIR149 mRNA CTD PMID:24552687 NCBI chr 2:240,456,001...240,456,089
Ensembl chr 2:240,456,001...240,456,089
JBrowse link
G MIR15B microRNA 15b increases expression EXP Rifampin results in increased expression of MIR15B mRNA CTD PMID:24552687 NCBI chr 3:160,404,588...160,404,685
Ensembl chr 3:160,404,588...160,404,685
JBrowse link
G MIR192 microRNA 192 decreases expression EXP Rifampin results in decreased expression of MIR192 mRNA CTD PMID:24552687 NCBI chr11:64,891,137...64,891,246
Ensembl chr11:64,891,137...64,891,246
JBrowse link
G MIR197 microRNA 197 decreases expression EXP Rifampin results in decreased expression of MIR197 mRNA CTD PMID:24552687 NCBI chr 1:109,598,893...109,598,967
Ensembl chr 1:109,598,893...109,598,967
JBrowse link
G MIR200A microRNA 200a increases expression EXP Rifampin results in increased expression of MIR200A mRNA CTD PMID:24552687 NCBI chr 1:1,167,863...1,167,952
Ensembl chr 1:1,167,863...1,167,952
JBrowse link
G MIR202 microRNA 202 increases expression EXP Rifampin results in increased expression of MIR202 mRNA CTD PMID:24552687 NCBI chr10:133,247,511...133,247,620
Ensembl chr10:133,247,511...133,247,620
JBrowse link
G MIR204 microRNA 204 increases expression EXP Rifampin results in increased expression of MIR204 mRNA CTD PMID:24552687 NCBI chr 9:70,809,975...70,810,084
Ensembl chr 9:70,809,975...70,810,084
JBrowse link
G MIR20B microRNA 20b increases expression EXP Rifampin results in increased expression of MIR20B mRNA CTD PMID:24552687 NCBI chr  X:134,169,809...134,169,877
Ensembl chr  X:134,169,809...134,169,877
JBrowse link
G MIR21 microRNA 21 increases expression EXP Rifampin results in increased expression of MIR21 mRNA CTD PMID:24552687 NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
JBrowse link
G MIR212 microRNA 212 decreases expression EXP Rifampin results in decreased expression of MIR212 mRNA CTD PMID:24552687 NCBI chr17:2,050,271...2,050,380
Ensembl chr17:2,050,271...2,050,380
JBrowse link
G MIR215 microRNA 215 increases expression EXP Rifampin results in increased expression of MIR215 mRNA CTD PMID:24552687 NCBI chr 1:220,117,853...220,117,962
Ensembl chr 1:220,117,853...220,117,962
JBrowse link
G MIR22 microRNA 22 increases expression EXP Rifampin results in increased expression of MIR22 mRNA CTD PMID:24552687 NCBI chr17:1,713,903...1,713,987
Ensembl chr17:1,713,903...1,713,987
JBrowse link
G MIR26B microRNA 26b increases expression EXP Rifampin results in increased expression of MIR26B mRNA CTD PMID:24552687 NCBI chr 2:218,402,646...218,402,722
Ensembl chr 2:218,402,646...218,402,722
JBrowse link
G MIR296 microRNA 296 decreases expression EXP Rifampin results in decreased expression of MIR296 mRNA CTD PMID:24552687 NCBI chr20:58,817,615...58,817,694
Ensembl chr20:58,817,615...58,817,694
JBrowse link
G MIR29A microRNA 29a decreases expression EXP Rifampin results in decreased expression of MIR29A mRNA CTD PMID:24552687 NCBI chr 7:130,876,747...130,876,810
Ensembl chr 7:130,876,747...130,876,810
JBrowse link
G MIR31 microRNA 31 increases expression EXP Rifampin results in increased expression of MIR31 mRNA CTD PMID:24552687 NCBI chr 9:21,512,115...21,512,185
Ensembl chr 9:21,512,115...21,512,185
JBrowse link
G MIR328 microRNA 328 increases expression EXP Rifampin results in increased expression of MIR328 mRNA CTD PMID:24552687 NCBI chr16:67,202,321...67,202,395
Ensembl chr16:67,202,321...67,202,395
JBrowse link
G MIR340 microRNA 340 increases expression EXP Rifampin results in increased expression of MIR340 mRNA CTD PMID:24552687 NCBI chr 5:180,015,303...180,015,397
Ensembl chr 5:180,015,303...180,015,397
JBrowse link
G MIR34A microRNA 34a decreases expression EXP Rifampin results in decreased expression of MIR34A mRNA CTD PMID:24552687 NCBI chr 1:9,151,668...9,151,777
Ensembl chr 1:9,151,668...9,151,777
JBrowse link
G MIR362 microRNA 362 decreases expression EXP Rifampin results in decreased expression of MIR362 mRNA CTD PMID:24552687 NCBI chr  X:50,008,964...50,009,028
Ensembl chr  X:50,008,964...50,009,028
JBrowse link
G MIR374B microRNA 374b increases expression EXP Rifampin results in increased expression of MIR374B mRNA CTD PMID:24552687 NCBI chr  X:74,218,547...74,218,618
Ensembl chr  X:74,218,547...74,218,618
JBrowse link
G MIR532 microRNA 532 decreases expression EXP Rifampin results in decreased expression of MIR532 mRNA CTD PMID:24552687 NCBI chr  X:50,003,148...50,003,238
Ensembl chr  X:50,003,148...50,003,238
JBrowse link
G MIR539 microRNA 539 increases expression EXP Rifampin results in increased expression of MIR539 mRNA CTD PMID:24552687 NCBI chr14:101,047,321...101,047,398
Ensembl chr14:101,047,321...101,047,398
JBrowse link
G MIR576 microRNA 576 increases expression EXP Rifampin results in increased expression of MIR576 mRNA CTD PMID:24552687 NCBI chr 4:109,488,698...109,488,795
Ensembl chr 4:109,488,698...109,488,795
JBrowse link
G MIR590 microRNA 590 increases expression EXP Rifampin results in increased expression of MIR590 mRNA CTD PMID:24552687 NCBI chr 7:74,191,198...74,191,294
Ensembl chr 7:74,191,198...74,191,294
JBrowse link
G MIR618 microRNA 618 decreases expression EXP Rifampin results in decreased expression of MIR618 mRNA CTD PMID:24552687 NCBI chr12:80,935,736...80,935,833
Ensembl chr12:80,935,736...80,935,833
JBrowse link
G MIR628 microRNA 628 decreases expression EXP Rifampin results in decreased expression of MIR628 mRNA CTD PMID:24552687 NCBI chr15:55,372,940...55,373,034
Ensembl chr15:55,372,940...55,373,034
JBrowse link
G MIR652 microRNA 652 decreases expression EXP Rifampin results in decreased expression of MIR652 mRNA CTD PMID:24552687 NCBI chr  X:110,055,329...110,055,426
Ensembl chr  X:110,055,329...110,055,426
JBrowse link
G MIR874 microRNA 874 decreases expression EXP Rifampin results in decreased expression of MIR874 mRNA CTD PMID:24552687 NCBI chr 5:137,647,572...137,647,649
Ensembl chr 5:137,647,572...137,647,649
JBrowse link
G MIR95 microRNA 95 increases expression EXP Rifampin results in increased expression of MIR95 mRNA CTD PMID:24552687 NCBI chr 4:8,005,301...8,005,381
Ensembl chr 4:8,005,301...8,005,381
JBrowse link
G MIRLET7E microRNA let-7e increases expression EXP Rifampin results in increased expression of MIRLET7E mRNA CTD PMID:24552687 NCBI chr19:51,692,786...51,692,864
Ensembl chr19:51,692,786...51,692,864
JBrowse link
G MKI67 marker of proliferation Ki-67 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein CTD PMID:21224054 NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
JBrowse link
G MMP3 matrix metallopeptidase 3 decreases secretion EXP Rifampin results in decreased secretion of MMP3 protein CTD PMID:24890593 NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
JBrowse link
G MPO myeloperoxidase multiple interactions ISO Rifampin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein] CTD PMID:24101390 NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
JBrowse link
G MR1 major histocompatibility complex, class I-related affects expression EXP Rifampin affects the expression of MR1 mRNA CTD PMID:25811541 NCBI chr 1:181,033,387...181,061,938
Ensembl chr 1:181,033,374...181,061,938
JBrowse link
G MTTP microsomal triglyceride transfer protein decreases expression EXP Rifampin results in decreased expression of MTTP mRNA CTD PMID:32535746 NCBI chr 4:99,564,130...99,623,997
Ensembl chr 4:99,564,081...99,623,997
JBrowse link
G MYH16 myosin heavy chain 16 pseudogene decreases expression EXP Rifampin results in decreased expression of MYH16 mRNA CTD PMID:24552687 NCBI chr 7:99,238,829...99,311,128
Ensembl chr 7:99,238,829...99,311,130
JBrowse link
G MYH6 myosin heavy chain 6 increases expression EXP Rifampin results in increased expression of MYH6 mRNA CTD PMID:24552687 NCBI chr14:23,381,987...23,408,273
Ensembl chr14:23,381,982...23,408,273
JBrowse link
G NAF1 nuclear assembly factor 1 ribonucleoprotein decreases expression EXP Rifampin results in decreased expression of NAF1 mRNA CTD PMID:24552687 NCBI chr 4:163,103,929...163,166,890
Ensembl chr 4:163,110,073...163,166,890
JBrowse link
G NAP1L5 nucleosome assembly protein 1 like 5 increases expression EXP Rifampin results in increased expression of NAP1L5 mRNA CTD PMID:24552687 NCBI chr 4:88,695,913...88,697,829
Ensembl chr 4:88,695,913...88,697,829
JBrowse link
G NCOA1 nuclear receptor coactivator 1 multiple interactions EXP Camptothecin inhibits the reaction [Rifampin promotes the reaction [NCOA1 protein binds to NR1I2 protein]]; Itraconazole promotes the reaction [Rifampin promotes the reaction [NR1I2 protein binds to NCOA1 protein]]; Ketoconazole inhibits the reaction [Rifampin promotes the reaction [NR1I2 protein binds to NCOA1 protein]]; Miconazole promotes the reaction [Rifampin results in increased expression of NCOA1 mRNA]; NCOA1 protein inhibits the reaction [[NR1I2 protein co-treated with Rifampin] results in decreased expression of SLC22A1 mRNA]; NCOA1 protein inhibits the reaction [[NR1I2 protein results in increased susceptibility to Rifampin] which results in decreased expression of SLC22A1 mRNA]; oxiconazole promotes the reaction [Rifampin promotes the reaction [NR1I2 protein binds to NCOA1 protein]]; pazopanib inhibits the reaction [Rifampin promotes the reaction [NCOA1 protein binds to NR1I2 protein]]; pimecrolimus inhibits the reaction [Rifampin promotes the reaction [NCOA1 protein binds to NR1I2 protein]]; Rifampin inhibits the reaction [NCOA1 protein binds to SLC22A1 promoter]; Rifampin inhibits the reaction [oxiconazole promotes the reaction [NR1I2 protein binds to NCOA1 protein]]; Rifampin promotes the reaction [[NCOA1 protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [[NR1I2 protein binds to NCOA1 protein] which binds to CYP27A1 gene]; Rifampin promotes the reaction [NCOA1 protein binds to and results in increased activity of NR1I2 protein]; Rifampin promotes the reaction [NCOA1 protein binds to HNF4A protein]; Rifampin promotes the reaction [NCOA1 protein binds to NR1I2 protein]; Rifampin promotes the reaction [NR1I2 protein binds to NCOA1 protein] CTD PMID:11581012 PMID:12072427 PMID:16819505 PMID:17088262 PMID:17438109 More... NCBI chr 2:24,491,254...24,770,702
Ensembl chr 2:24,491,254...24,770,702
JBrowse link
G NCOA2 nuclear receptor coactivator 2 multiple interactions EXP Rifampin promotes the reaction [NCOA2 protein binds to HNF4A protein] CTD PMID:21292004 NCBI chr 8:70,109,782...70,456,446
Ensembl chr 8:70,109,782...70,403,808
JBrowse link
G NCOA6 nuclear receptor coactivator 6 multiple interactions EXP NCOA6 promotes the reaction [Rifampin promotes the reaction [[HNF4A co-treated with NR1I2] results in increased expression of CYP2C9 mRNA]]; Rifampin promotes the reaction [[HNF4A co-treated with NCOA6] results in increased expression of CYP2C9 mRNA]; Rifampin promotes the reaction [[HNF4A co-treated with NCOA6] results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [NCOA6 protein binds to HNF4A protein] CTD PMID:21292004 NCBI chr20:34,714,774...34,825,651
Ensembl chr20:34,689,097...34,825,651
JBrowse link
G NCOR1 nuclear receptor corepressor 1 multiple interactions EXP Rifampin inhibits the reaction [NCOR1 protein binds to and results in decreased activity of NR1I2 protein] CTD PMID:22214767 NCBI chr17:16,029,157...16,215,534
Ensembl chr17:16,029,157...16,218,185
JBrowse link
G NCOR2 nuclear receptor corepressor 2 multiple interactions EXP [NR1I2 protein binds to NCOR2 protein] inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Rifampin inhibits the reaction [NCOR2 protein binds to and results in decreased activity of NR1I2 protein]; Rifampin inhibits the reaction [NCOR2 protein binds to NR1I2 protein]; Rifampin inhibits the reaction [NR1I2 protein binds to NCOR2 protein]; Rifampin inhibits the reaction [trichostatin A inhibits the reaction [[PIAS1 co-treated with SUMO3] inhibits the reaction [NCOR2 protein promotes the reaction [NR1I2 protein binds to HDAC3 protein]]]]; Rifampin promotes the reaction [NR1I2 protein binds to NCOR2 protein] CTD PMID:12072427 PMID:22214767 PMID:25313206 PMID:26883953 PMID:28289823 More... NCBI chr12:124,324,415...124,567,612
Ensembl chr12:124,324,415...124,567,589
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 increases expression
decreases activity
multiple interactions
EXP
ISO
Rifampin results in increased expression of NFE2L2 protein
Rifampin results in decreased activity of NFE2L2 protein
Rifampin inhibits the reaction [arsenite results in increased activity of NFE2L2 protein]
CTD PMID:31678598 PMID:33412187 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,227,595...177,392,697
JBrowse link
G NFYA nuclear transcription factor Y subunit alpha decreases expression EXP Rifampin results in decreased expression of NFYA mRNA CTD PMID:24552687 NCBI chr 6:41,072,974...41,102,403
Ensembl chr 6:41,072,974...41,102,403
JBrowse link
G NKAPP1 NFKB activating protein pseudogene 1 increases expression EXP Rifampin results in increased expression of NKAPP1 mRNA CTD PMID:24552687 NCBI chr  X:120,236,452...120,245,267
Ensembl chr  X:120,120,953...120,245,273
JBrowse link
G NLRP3 NLR family pyrin domain containing 3 multiple interactions ISO Rifampin inhibits the reaction [Rotenone results in increased expression of NLRP3 protein] CTD PMID:26086368 NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions
increases expression
ISO
EXP
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of NOS2 mRNA
Rifampin results in increased expression of NOS2 mRNA
CTD PMID:21224054 PMID:24552687 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
JBrowse link
G NPAS1 neuronal PAS domain protein 1 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of NPAS1 mRNA CTD PMID:21127053 NCBI chr19:47,019,837...47,045,775
Ensembl chr19:47,019,837...47,045,775
JBrowse link
G NPPB natriuretic peptide B multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of NPPB mRNA CTD PMID:21127053 NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
JBrowse link
G NR0B2 nuclear receptor subfamily 0 group B member 2 increases expression
decreases expression
EXP Rifampin results in increased expression of NR0B2 mRNA
Rifampin results in decreased expression of NR0B2 mRNA
CTD PMID:15670600 PMID:34689256 NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
JBrowse link
G NR1H3 nuclear receptor subfamily 1 group H member 3 multiple interactions EXP NR1H3 mutant form inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA] CTD PMID:23732298 NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 affects response to substance
decreases acetylation
affects localization
increases response to substance
increases activity
decreases response to substance
multiple interactions
increases expression
increases localization
affects binding
EXP
ISO
NR1I2 protein affects the susceptibility to Rifampin
Rifampin results in decreased acetylation of NR1I2 protein
Rifampin affects the localization of NR1I2 protein
NR1I2 protein results in increased susceptibility to Rifampin
[Rifampin results in increased activity of NR1I2 protein] which results in increased activity of CYP3A4 protein; Rifampin results in increased activity of NR1I2 protein
NR1I2 protein mutant form results in decreased susceptibility to Rifampin
1,5-benzothiazepine analog promotes the reaction [[Rifampin co-treated with RXRA] results in increased activity of NR1I2 protein]; 7-acetoxy-6,7-dihydro-6-(4-methoxyphenyl)pyrrolo(2,1-d)(1,5)benzothiazepine inhibits the reaction [[Rifampin co-treated with RXRA] results in increased activity of NR1I2 protein]; [[Rifampin results in increased activity of NR1I2 protein] which results in increased activity of CYP3A4 protein] which results in increased metabolism of and results in increased activity of and results in increased susceptibility to Cobicistat; [fexofenadine co-treated with Rifampin] results in increased activity of NR1I2 protein; [Ketoconazole co-treated with Rifampin] results in increased activity of NR1I2 protein; [Loperamide co-treated with Rifampin] results in increased activity of NR1I2 protein; [NR1I2 protein binds to NCOR2 protein] inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; [NR1I2 protein co-treated with Rifampin] results in decreased expression of CYP3A4 mRNA; [NR1I2 protein co-treated with Rifampin] results in decreased expression of SLC22A1 mRNA; [NR1I2 protein co-treated with Rifampin] results in decreased expression of SULT1E1 mRNA; [NR1I2 protein results in increased susceptibility to Rifampin] which results in decreased expression of SLC22A1 mRNA; [NR1I2 protein results in increased susceptibility to Rifampin] which results in increased expression of ABCB1 mRNA; [NR1I2 protein results in increased susceptibility to Rifampin] which results in increased expression of ABCB1 protein; [NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin; [Rifampin binds to and results in increased activity of NR1I2 protein] promotes the reaction [ABCB1 protein results in decreased uptake of Doxorubicin]; [Rifampin binds to and results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; [Rifampin binds to and results in increased activity of NR1I2 protein] which results in increased expression of FGF19 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of NR1I2 protein; [Rifampin co-treated with NR1I2 protein] results in decreased expression of CYP8B1 mRNA; [Rifampin co-treated with NR1I2 protein] results in decreased expression of FOXA1 mRNA; [Rifampin co-treated with NR1I2 protein] results in decreased expression of GATA5 mRNA; [Rifampin co-treated with NR1I2 protein] results in decreased expression of HDAC5 mRNA; [Rifampin co-treated with NR1I2 protein] results in decreased expression of HNF4A mRNA; [Rifampin co-treated with NR1I2 protein] results in decreased expression of SERPINA4 mRNA; [Rifampin co-treated with NR1I2 protein] results in decreased expression of STAT5A mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of ANGPTL4 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of AQP3 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of BHLHE40 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of BMP4 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of CCN1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of CCR6 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of CCR7 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of CDKN2B mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of CYP26A1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of CYP2B6 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of CYP2S1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of CYP3A4 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of EDN1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of EGR1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of EGR2 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of EGR4 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of EPAS1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of G6PC1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of HBEGF mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of HEY1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of HIF1A mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of IGFBP1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of IGFBP3 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of IGFBP4 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of JUN mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of KLF2 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of KLF5 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of KLF6 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of LEFTY1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of MAFF mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of NPAS1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of NPPB mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of PCK1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of PIP4K2A mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of SERPINB1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of SERPINB8 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of SERPINB9 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of SERPINE1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of SGK2 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of SGK2 protein; [Rifampin co-treated with NR1I2 protein] results in increased expression of SMAD9 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of SOCS3 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of UGT1A1 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of VEGFD mRNA; [Rifampin co-treated with RXRA] results in increased activity of NR1I2 protein; [Rifampin results in increased activity of NR1I2 protein] inhibits the reaction [HNF4A protein binds to SULT1E1 enhancer]; [Rifampin results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 protein; [Rifampin results in increased activity of NR1I2 protein] which results in increased expression of ABCC3 mRNA; [Rifampin results in increased activity of NR1I2 protein] which results in increased expression of CYP2B6 mRNA; [Rifampin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; [Rifampin results in increased activity of NR1I2 protein] which results in increased expression of DHCR24 mRNA; [Rifampin results in increased expression of NR1I2 protein] which results in increased expression of and results in increased activity of CYP3A4 protein; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [[HNF4A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]]; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [[PPARGC1A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]]; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [[RXRA protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]]; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [[SRC protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]]; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]]; Camptothecin inhibits the reaction [Rifampin promotes the reaction [NCOA1 protein binds to NR1I2 protein]]; Camptothecin inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; caraway oil inhibits the reaction [Rifampin results in increased expression of NR1I2 mRNA]; Clove Oil inhibits the reaction [Rifampin results in increased expression of NR1I2 mRNA]; coriander oil inhibits the reaction [Rifampin results in increased expression of NR1I2 mRNA]; Dexamethasone promotes the reaction [NR3C1 protein affects the reaction [NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP2B6 mRNA]]]; Doxorubicin inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; enilconazole inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; Epirubicin inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; Fluconazole inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; hydroxyitraconazole inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; INS protein inhibits the reaction [[Rifampin co-treated with NR1I2 protein] results in increased expression of G6PC1 mRNA]; Itraconazole promotes the reaction [Rifampin promotes the reaction [NR1I2 protein binds to NCOA1 protein]]; Itraconazole promotes the reaction [Rifampin results in increased expression of NR1I2 mRNA]; jasmine oil inhibits the reaction [Rifampin results in increased expression of NR1I2 mRNA]; Ketoconazole inhibits the reaction [NR1I2 protein promotes the reaction [Rifampin results in increased expression of ABCB1 mRNA]]; Ketoconazole inhibits the reaction [NR1I2 protein promotes the reaction [Rifampin results in increased expression of ABCB1 protein]]; Ketoconazole inhibits the reaction [NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]]; Ketoconazole inhibits the reaction [NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP3A4 protein]]; Ketoconazole inhibits the reaction [Rifampin binds to and results in increased activity of NR1I2 protein]; Ketoconazole inhibits the reaction [Rifampin promotes the reaction [NR1I2 protein binds to NCOA1 protein]]; Ketoconazole inhibits the reaction [Rifampin promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]; Ketoconazole inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; lemongrass oil inhibits the reaction [Rifampin results in increased expression of NR1I2 mRNA]; Miconazole inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; mulberroside A inhibits the reaction [[NR1I2 protein results in increased susceptibility to Rifampin] which results in increased expression of ABCB1 mRNA]; mulberroside A inhibits the reaction [[NR1I2 protein results in increased susceptibility to Rifampin] which results in increased expression of ABCB1 protein]; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Rifampin promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]; NCOA1 protein inhibits the reaction [[NR1I2 protein co-treated with Rifampin] results in decreased expression of SLC22A1 mRNA]; NCOA1 protein inhibits the reaction [[NR1I2 protein results in increased susceptibility to Rifampin] which results in decreased expression of SLC22A1 mRNA]; NCOA6 promotes the reaction [Rifampin promotes the reaction [[HNF4A co-treated with NR1I2] results in increased expression of CYP2C9 mRNA]]; NR1I2 gene promotes the reaction [Rifampin results in increased expression of CYP3A4 protein]; NR1I2 gene promotes the reaction [Rifampin results in increased metabolism of amprenavir]; NR1I2 gene promotes the reaction [Rifampin results in increased metabolism of Midazolam]; NR1I2 gene promotes the reaction [Rifampin results in increased metabolism of Nelfinavir]; NR1I2 gene promotes the reaction [Rifampin results in increased metabolism of Saquinavir]; NR1I2 mRNA promotes the reaction [Rifampin results in increased expression of CYP2B6 mRNA]; NR1I2 mRNA promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; NR1I2 protein affects the reaction [Rifampin results in increased expression of and results in increased activity of CYP2B6 protein]; NR1I2 protein affects the reaction [Rifampin results in increased expression of CYP2C9 mRNA]; NR1I2 protein affects the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; NR1I2 protein affects the reaction [Rifampin results in increased expression of CYP3A4 protein]; NR1I2 protein inhibits the reaction [[Rifampin co-treated with Benzo(a)pyrene] results in increased expression of AHR mRNA]; NR1I2 protein inhibits the reaction [Thapsigargin inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]]; NR1I2 protein promotes the reaction [[HNF4A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [[PPARGC1A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [[RXRA protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [[SRC protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [Rifampin results in decreased expression of CYP7A1 mRNA]; NR1I2 protein promotes the reaction [Rifampin results in decreased expression of GCK protein]; NR1I2 protein promotes the reaction [Rifampin results in decreased expression of SLC2A2 protein]; NR1I2 protein promotes the reaction [Rifampin results in increased abundance of Lipids]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of ABCB1 mRNA]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of ABCB1 protein]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of CES2 mRNA]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP24A1 mRNA]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP2B6 mRNA]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP3A4 protein]; NR1I2 protein promotes the reaction [Rifampin results in increased expression of GADD45B mRNA]; ochratoxin A inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; Oils, Volatile inhibits the reaction [Rifampin results in increased expression of NR1I2 mRNA]; Oils, Volatile promotes the reaction [Rifampin results in increased expression of NR1I2 mRNA]; oxiconazole inhibits the reaction [Rifampin promotes the reaction [NR1I2 results in increased expression of CYP3A4 mRNA]]; oxiconazole inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; oxiconazole promotes the reaction [Rifampin promotes the reaction [NR1I2 protein binds to NCOA1 protein]]; pazopanib inhibits the reaction [Rifampin promotes the reaction [NCOA1 protein binds to NR1I2 protein]]; pazopanib inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; pimecrolimus inhibits the reaction [Rifampin promotes the reaction [NCOA1 protein binds to NR1I2 protein]]; pimecrolimus inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; PK 11195 inhibits the reaction [[Rifampin co-treated with RXRA] results in increased activity of NR1I2 protein]; Rifampin binds to and results in increased activity of NR1I2 protein; Rifampin inhibits the reaction [NCOR1 protein binds to and results in decreased activity of NR1I2 protein]; Rifampin inhibits the reaction [NCOR2 protein binds to and results in decreased activity of NR1I2 protein]; Rifampin inhibits the reaction [NCOR2 protein binds to NR1I2 protein]; Rifampin inhibits the reaction [NR1I2 protein binds to NCOR2 protein]; Rifampin inhibits the reaction [oxiconazole promotes the reaction [NR1I2 protein binds to NCOA1 protein]]; Rifampin inhibits the reaction [oxiconazole results in increased expression of NR1I2 mRNA]; Rifampin inhibits the reaction [trichostatin A inhibits the reaction [[PIAS1 co-treated with SUMO3] inhibits the reaction [NCOR2 protein promotes the reaction [NR1I2 protein binds to HDAC3 protein]]]]; Rifampin inhibits the reaction [trichostatin A results in increased acetylation of NR1I2 protein]; Rifampin promotes the reaction [[HNF4A co-treated with NR1I2] results in increased expression of CYP2C9 mRNA]; Rifampin promotes the reaction [[HNF4A co-treated with NR1I2] results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [[NCOA1 protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [[NR1I2 protein binds to NCOA1 protein] which binds to CYP27A1 gene]; Rifampin promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [MED1 protein binds to and results in increased activity of NR1I2 protein]; Rifampin promotes the reaction [NCOA1 protein binds to and results in increased activity of NR1I2 protein]; Rifampin promotes the reaction [NCOA1 protein binds to NR1I2 protein]; Rifampin promotes the reaction [NR1I2 protein binds to ABCB1 promoter]; Rifampin promotes the reaction [NR1I2 protein binds to CYP24A1 promoter]; Rifampin promotes the reaction [NR1I2 protein binds to CYP2A6 promoter]; Rifampin promotes the reaction [NR1I2 protein binds to CYP3A4 promoter]; Rifampin promotes the reaction [NR1I2 protein binds to HNF4A protein]; Rifampin promotes the reaction [NR1I2 protein binds to NCOA1 protein]; Rifampin promotes the reaction [NR1I2 protein binds to NCOR2 protein]; Rifampin promotes the reaction [NR1I2 protein binds to SGK2 promoter]; Rifampin promotes the reaction [NR1I2 protein results in decreased expression of SLC22A1 mRNA]; Rifampin promotes the reaction [NR1I2 protein results in increased expression of CYP2C9 mRNA]; Rifampin promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [NR1I2 results in increased expression of CYP3A4 mRNA]; SGK2 mutant form inhibits the reaction [[Rifampin co-treated with NR1I2 protein] results in increased expression of G6PC1 mRNA]; SGK2 mutant form inhibits the reaction [[Rifampin co-treated with NR1I2 protein] results in increased expression of PCK1 mRNA]; sodium arsenite inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; sulforaphane inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]; trichostatin A affects the reaction [Rifampin affects the localization of NR1I2 protein]
Rifampin results in increased expression of NR1I2 mRNA; Rifampin results in increased expression of NR1I2 protein
Rifampin results in increased localization of NR1I2 protein
[Rifampin co-treated with NR1I2 protein] results in increased expression of CYP3A23-3A1 mRNA; [Rifampin promotes the reaction [[NR1I2 protein co-treated with RXRA protein] binds to SULT2A1 promoter]] which results in increased expression of SULT2A1 mRNA; arsenite inhibits the reaction [Rifampin results in increased localization of NR1I2 protein]; Rifampin promotes the reaction [[NR1I2 protein co-treated with RXRA protein] binds to CYP3A23-3A1 promoter]; Rifampin promotes the reaction [[NR1I2 protein co-treated with RXRA protein] binds to SULT2A1 promoter]; sodium arsenite inhibits the reaction [[Rifampin co-treated with NR1I2 protein] results in increased expression of CYP3A23-3A1 mRNA]
Rifampin binds to NR1I2 gene mutant form
[[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in decreased expression of CYP1A2 protein; [[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in decreased expression of CYP2E1 protein; [[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in increased expression of CYP2B10 protein; [[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in increased expression of CYP2C protein; [[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in increased expression of CYP3A11 protein; [Rifampin binds to NR1I2 gene mutant form] which results in increased expression of CES2A mRNA; [Rifampin binds to NR1I2 gene mutant form] which results in increased expression of CYP3A11 mRNA; [Rifampin promotes the reaction [[NR1I2 protein co-treated with RXRA protein] binds to SULT2A1 promoter]] which results in increased expression of SULT2A1 mRNA; NR1I2 affects the reaction [Rifampin results in increased activity of CYP3A4 protein]; Rifampin affects the localization of and results in increased activity of NR1I2 protein; Rifampin promotes the reaction [[NR1I2 protein co-treated with RXRA protein] binds to SULT2A1 promoter]
[Rifampin binds to NR1I2 protein] which binds to CYP2C8 promoter; Rifampin binds to NR1I2 protein
CTD PMID:11581012 PMID:12065438 PMID:12072427 PMID:12370413 PMID:12417264 More... NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 increases expression
multiple interactions
ISO
EXP
Rifampin results in increased expression of NR1I3 mRNA
[[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in decreased expression of CYP1A2 protein; [[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in decreased expression of CYP2E1 protein; [[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in increased expression of CYP2B10 protein; [[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in increased expression of CYP2C protein; [[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in increased expression of CYP3A11 protein
Rifampin results in increased expression of NR1I3 mRNA; Rifampin results in increased expression of NR1I3 protein
[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin; [Rifampin co-treated with Monocrotophos] results in increased expression of NR1I3 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of NR1I3 protein
CTD PMID:19118567 PMID:22733800 PMID:25835148 NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
JBrowse link
G NR3C1 nuclear receptor subfamily 3 group C member 1 multiple interactions
increases expression
EXP Dexamethasone promotes the reaction [NR3C1 protein affects the reaction [NR1I2 protein promotes the reaction [Rifampin results in increased expression of CYP2B6 mRNA]]]; NR3C1 protein promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]
Rifampin results in increased expression of NR3C1 mRNA
CTD PMID:10219967 PMID:12673034 PMID:12695351 NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
JBrowse link
G NRL neural retina leucine zipper increases expression EXP Rifampin results in increased expression of NRL mRNA CTD PMID:24552687 NCBI chr14:24,078,662...24,114,949
Ensembl chr14:24,078,662...24,115,010
JBrowse link
G OBSL1 obscurin like cytoskeletal adaptor 1 decreases expression EXP Rifampin results in decreased expression of OBSL1 mRNA CTD PMID:24552687 NCBI chr 2:219,547,206...219,571,539
Ensembl chr 2:219,550,728...219,571,859
JBrowse link
G OCLN occludin affects localization ISO Rifampin affects the localization of OCLN protein CTD PMID:19577586 NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
JBrowse link
G OR4A47 olfactory receptor family 4 subfamily A member 47 decreases expression EXP Rifampin results in decreased expression of OR4A47 mRNA CTD PMID:24552687 NCBI chr11:48,488,793...48,489,722
Ensembl chr11:48,488,793...48,489,722
JBrowse link
G P4HB prolyl 4-hydroxylase subunit beta decreases expression EXP Rifampin results in decreased expression of P4HB mRNA CTD PMID:32535746 NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 multiple interactions EXP Rifampin inhibits the reaction [[Acetaminophen co-treated with [ferric nitrate results in increased abundance of Iron]] results in increased cleavage of PARP1 protein] CTD PMID:31678598 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
JBrowse link
G PAX7 paired box 7 decreases expression EXP Rifampin results in decreased expression of PAX7 mRNA CTD PMID:24552687 NCBI chr 1:18,630,846...18,748,866
Ensembl chr 1:18,630,846...18,748,866
JBrowse link
G PCK1 phosphoenolpyruvate carboxykinase 1 multiple interactions
increases expression
EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of PCK1 mRNA; SGK2 mutant form inhibits the reaction [[Rifampin co-treated with NR1I2 protein] results in increased expression of PCK1 mRNA]
Rifampin results in increased expression of PCK1 mRNA
CTD PMID:24204015 PMID:34689256 NCBI chr20:57,561,110...57,568,121
Ensembl chr20:57,561,080...57,568,121
JBrowse link
G PCLAF PCNA clamp associated factor increases expression EXP Rifampin results in increased expression of PCLAF mRNA CTD PMID:24552687 NCBI chr15:64,364,304...64,387,687
Ensembl chr15:64,364,304...64,387,687
JBrowse link
G PDAP1 PDGFA associated protein 1 decreases expression EXP Rifampin results in decreased expression of PDAP1 mRNA CTD PMID:24552687 NCBI chr 7:99,394,673...99,408,597
Ensembl chr 7:99,392,048...99,408,597
JBrowse link
G PDE4D phosphodiesterase 4D decreases expression EXP Rifampin results in decreased expression of PDE4D mRNA CTD PMID:24552687 NCBI chr 5:58,969,038...60,522,128
Ensembl chr 5:58,969,038...60,522,120
JBrowse link
G PEG3 paternally expressed 3 increases expression EXP Rifampin results in increased expression of PEG3 mRNA CTD PMID:24552687 NCBI chr19:56,810,082...56,840,726
Ensembl chr19:56,810,077...56,840,728
JBrowse link
G PIAS1 protein inhibitor of activated STAT 1 multiple interactions EXP Rifampin inhibits the reaction [trichostatin A inhibits the reaction [[PIAS1 co-treated with SUMO3] inhibits the reaction [NCOR2 protein promotes the reaction [NR1I2 protein binds to HDAC3 protein]]]] CTD PMID:26883953 NCBI chr15:68,054,315...68,193,847
Ensembl chr15:68,054,309...68,198,603
JBrowse link
G PILRA paired immunoglobin like type 2 receptor alpha decreases expression EXP Rifampin results in decreased expression of PILRA mRNA CTD PMID:24552687 NCBI chr 7:100,371,291...100,400,096
Ensembl chr 7:100,367,530...100,400,096
JBrowse link
G PIP4K2A phosphatidylinositol-5-phosphate 4-kinase type 2 alpha multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of PIP4K2A mRNA CTD PMID:21127053 NCBI chr10:22,534,854...22,714,578
Ensembl chr10:22,534,854...22,714,578
JBrowse link
G PKD2L1 polycystin 2 like 1, transient receptor potential cation channel decreases expression EXP Rifampin results in decreased expression of PKD2L1 mRNA CTD PMID:24552687 NCBI chr10:100,288,149...100,330,228
Ensembl chr10:100,288,149...100,330,264
JBrowse link
G PKLR pyruvate kinase L/R increases expression EXP Rifampin results in increased expression of PKLR mRNA CTD PMID:24552687 NCBI chr 1:155,289,293...155,308,654
Ensembl chr 1:155,289,293...155,301,438
JBrowse link
G PLAAT2 phospholipase A and acyltransferase 2 decreases expression EXP Rifampin results in decreased expression of PLAAT2 mRNA CTD PMID:24552687 NCBI chr11:63,552,770...63,565,070
Ensembl chr11:63,552,770...63,563,379
JBrowse link
G PLAT plasminogen activator, tissue type decreases expression EXP Rifampin results in decreased expression of PLAT mRNA CTD PMID:24552687 NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
JBrowse link
G PON1 paraoxonase 1 increases expression EXP Rifampin results in increased expression of PON1 mRNA CTD PMID:26434531 NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
JBrowse link
G POR cytochrome p450 oxidoreductase increases activity ISO Rifampin results in increased activity of POR protein CTD PMID:12051692 NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
JBrowse link
G POU2F1 POU class 2 homeobox 1 decreases expression EXP Rifampin results in decreased expression of POU2F1 mRNA CTD PMID:16837569 NCBI chr 1:167,220,885...167,427,345
Ensembl chr 1:167,220,876...167,427,345
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha multiple interactions EXP [Rifampin co-treated with PPARA protein co-treated with RXRA protein] results in decreased expression of UGDH mRNA CTD PMID:16292757 NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
JBrowse link
G PPARG peroxisome proliferator activated receptor gamma multiple interactions
increases expression
ISO [Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of PPARG mRNA; [Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of PPARG mRNA alternative form; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA alternative form]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG protein]; Rifampin results in increased expression of and affects the localization of PPARG protein
Rifampin results in increased expression of PPARG mRNA
CTD PMID:27806127 PMID:33412187 NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
JBrowse link
G PPARGC1A PPARG coactivator 1 alpha multiple interactions EXP [PPARGC1A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA; allyl isothiocyanate inhibits the reaction [[PPARGC1A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [[PPARGC1A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]]; NR1I2 protein promotes the reaction [[PPARGC1A protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; Rifampin promotes the reaction [PPARGC1A protein binds to CYP2A6 promoter]; Rifampin promotes the reaction [PPARGC1A protein binds to HNF4A protein] CTD PMID:16857725 PMID:21292004 PMID:25069801 NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
JBrowse link
G PRKDC protein kinase, DNA-activated, catalytic subunit multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of ATM mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of ATM protein; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CCND1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CHEK2 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP1B1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP2A5 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP2B9 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP4A10 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP4A14 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP7A1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of DNAJA1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of EGR1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FASL mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO4 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of HSPD1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of HSPE1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of IL18 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of IL1B mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of RAD50 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TNFSF10 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TRADD mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of XRCC4 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of ANXA5 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BAX mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BCL2L1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CCNG1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CDKN1A mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CDKN1A protein; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CXCL10 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP2B10 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP3A11 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP3A4 protein; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of DDIT3 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of E2F1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GADD45A mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GPX2 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM1 protein; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM3 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HMOX1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA1L mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA8 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPB1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of IL6 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of MDM2 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of NOS2 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of SERPINE1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of UNG mRNA; PRKDC gene mutant form results in increased susceptibility to [Rifampin co-treated with Phenytoin co-treated with Monocrotaline] CTD PMID:21224054 NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178
JBrowse link
G PRMT1 protein arginine methyltransferase 1 multiple interactions EXP PRMT1 protein affects the reaction [[Dimethyl Sulfoxide results in increased susceptibility to Rifampin] which results in increased expression of CYP3A4 mRNA]; PRMT1 protein affects the reaction [Dimethyl Sulfoxide promotes the reaction [Rifampin results in increased expression of CYP3A4 mRNA]]; PRMT1 protein affects the reaction [Rifampin results in increased expression of CYP3A4 mRNA] CTD PMID:31877331 NCBI chr19:49,676,153...49,688,447
Ensembl chr19:49,675,786...49,689,029
JBrowse link
G PRUNE1 prune exopolyphosphatase 1 decreases expression EXP Rifampin results in decreased expression of PRUNE1 mRNA CTD PMID:24552687 NCBI chr 1:151,008,449...151,035,713
Ensembl chr 1:151,008,420...151,035,713
JBrowse link
G PSIP1 PC4 and SFRS1 interacting protein 1 increases expression EXP Rifampin results in increased expression of PSIP1 mRNA CTD PMID:24552687 NCBI chr 9:15,464,066...15,510,970
Ensembl chr 9:15,464,066...15,510,995
JBrowse link
G PSMC3IP PSMC3 interacting protein increases expression EXP Rifampin results in increased expression of PSMC3IP mRNA CTD PMID:24552687 NCBI chr17:42,572,310...42,577,831
Ensembl chr17:42,572,310...42,577,831
JBrowse link
G RAD50 RAD50 double strand break repair protein multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of RAD50 mRNA CTD PMID:21224054 NCBI chr 5:132,556,977...132,646,349
Ensembl chr 5:132,556,019...132,646,349
JBrowse link
G RGPD6 RANBP2 like and GRIP domain containing 6 decreases expression EXP Rifampin results in decreased expression of RGPD6 mRNA CTD PMID:24552687 NCBI chr 2:110,513,802...110,611,056
Ensembl chr 2:110,513,802...110,610,840
JBrowse link
G RIC8B RIC8 guanine nucleotide exchange factor B decreases expression EXP Rifampin results in decreased expression of RIC8B mRNA CTD PMID:24552687 NCBI chr12:106,774,682...106,889,316
Ensembl chr12:106,774,621...106,889,316
JBrowse link
G RNA5-8SN4 RNA, 5.8S ribosomal N4 decreases expression EXP Rifampin results in decreased expression of RNA5-8SN4 mRNA CTD PMID:24552687
G RNF6 ring finger protein 6 decreases expression EXP Rifampin results in decreased expression of RNF6 mRNA CTD PMID:24552687 NCBI chr13:26,132,115...26,223,085
Ensembl chr13:26,132,115...26,222,314
JBrowse link
G RRAGB Ras related GTP binding B decreases expression EXP Rifampin results in decreased expression of RRAGB mRNA CTD PMID:24552687 NCBI chr  X:55,717,749...55,758,774
Ensembl chr  X:55,717,749...55,758,774
JBrowse link
G RSPO3 R-spondin 3 decreases expression EXP Rifampin results in decreased expression of RSPO3 mRNA CTD PMID:24552687 NCBI chr 6:127,118,671...127,199,481
Ensembl chr 6:127,118,671...127,199,481
JBrowse link
G RXRA retinoid X receptor alpha multiple interactions EXP
ISO
1,5-benzothiazepine analog promotes the reaction [[Rifampin co-treated with RXRA] results in increased activity of NR1I2 protein]; 7-acetoxy-6,7-dihydro-6-(4-methoxyphenyl)pyrrolo(2,1-d)(1,5)benzothiazepine inhibits the reaction [[Rifampin co-treated with RXRA] results in increased activity of NR1I2 protein]; [Rifampin co-treated with PPARA protein co-treated with RXRA protein] results in decreased expression of UGDH mRNA; [Rifampin co-treated with RXRA] results in increased activity of NR1I2 protein; [RXRA protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA; allyl isothiocyanate inhibits the reaction [[RXRA protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [[RXRA protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]]; NR1I2 protein promotes the reaction [[RXRA protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; PK 11195 inhibits the reaction [[Rifampin co-treated with RXRA] results in increased activity of NR1I2 protein]; Rifampin promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]
[Rifampin promotes the reaction [[NR1I2 protein co-treated with RXRA protein] binds to SULT2A1 promoter]] which results in increased expression of SULT2A1 mRNA; Rifampin promotes the reaction [[NR1I2 protein co-treated with RXRA protein] binds to CYP3A23-3A1 promoter]; Rifampin promotes the reaction [[NR1I2 protein co-treated with RXRA protein] binds to SULT2A1 promoter]
[Rifampin promotes the reaction [[NR1I2 protein co-treated with RXRA protein] binds to SULT2A1 promoter]] which results in increased expression of SULT2A1 mRNA; Rifampin promotes the reaction [[NR1I2 protein co-treated with RXRA protein] binds to SULT2A1 promoter]
CTD PMID:12370413 PMID:16292757 PMID:16632523 PMID:21315811 PMID:25069801 NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585
JBrowse link
G SCARB1 scavenger receptor class B member 1 decreases expression EXP Rifampin results in decreased expression of SCARB1 mRNA; Rifampin results in decreased expression of SCARB1 protein CTD PMID:15883047 NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
JBrowse link
G SEMA3F-AS1 SEMA3F antisense RNA 1 decreases expression EXP Rifampin results in decreased expression of SEMA3F-AS1 mRNA CTD PMID:24552687 NCBI chr 3:50,116,022...50,156,085
Ensembl chr 3:50,116,022...50,156,085
JBrowse link
G SEPTIN8 septin 8 increases expression EXP Rifampin results in increased expression of SEPTIN8 mRNA CTD PMID:24552687 NCBI chr 5:132,750,819...132,780,083
Ensembl chr 5:132,750,819...132,807,241
JBrowse link
G SERPINA4 serpin family A member 4 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in decreased expression of SERPINA4 mRNA CTD PMID:21127053 NCBI chr14:94,561,442...94,569,906
Ensembl chr14:94,561,442...94,569,913
JBrowse link
G SERPINB1 serpin family B member 1 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of SERPINB1 mRNA CTD PMID:21127053 NCBI chr 6:2,832,332...2,841,863
Ensembl chr 6:2,832,332...2,841,959
JBrowse link
G SERPINB8 serpin family B member 8 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of SERPINB8 mRNA CTD PMID:21127053 NCBI chr18:63,970,081...64,019,779
Ensembl chr18:63,970,029...64,019,779
JBrowse link
G SERPINB9 serpin family B member 9 multiple interactions
increases expression
EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of SERPINB9 mRNA
Rifampin results in increased expression of SERPINB9 mRNA
CTD PMID:21127053 PMID:24552687 NCBI chr 6:2,887,270...2,903,309
Ensembl chr 6:2,887,270...2,903,309
JBrowse link
G SERPINE1 serpin family E member 1 multiple interactions ISO
EXP
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of SERPINE1 mRNA
[Rifampin co-treated with NR1I2 protein] results in increased expression of SERPINE1 mRNA
CTD PMID:21127053 PMID:21224054 NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
JBrowse link
G SFXN1 sideroflexin 1 decreases expression EXP Rifampin results in decreased expression of SFXN1 mRNA CTD PMID:24552687 NCBI chr 5:175,478,560...175,529,742
Ensembl chr 5:175,477,062...175,529,742
JBrowse link
G SGK2 serum/glucocorticoid regulated kinase 2 multiple interactions
increases expression
EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of SGK2 mRNA; [Rifampin co-treated with NR1I2 protein] results in increased expression of SGK2 protein; Rifampin promotes the reaction [NR1I2 protein binds to SGK2 promoter]; SGK2 mutant form affects the reaction [Rifampin affects the expression of G6PC1 mRNA]; SGK2 mutant form inhibits the reaction [[Rifampin co-treated with NR1I2 protein] results in increased expression of G6PC1 mRNA]; SGK2 mutant form inhibits the reaction [[Rifampin co-treated with NR1I2 protein] results in increased expression of PCK1 mRNA]
Rifampin results in increased expression of SGK2 mRNA
CTD PMID:21127053 PMID:24204015 NCBI chr20:43,559,027...43,585,627
Ensembl chr20:43,558,968...43,588,237
JBrowse link
G SIK2 salt inducible kinase 2 decreases expression EXP Rifampin results in decreased expression of SIK2 mRNA CTD PMID:24552687 NCBI chr11:111,602,449...111,730,855
Ensembl chr11:111,602,449...111,730,855
JBrowse link
G SLC10A1 solute carrier family 10 member 1 decreases expression EXP Rifampin results in decreased expression of SLC10A1 mRNA CTD PMID:16837569 NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
JBrowse link
G SLC13A5 solute carrier family 13 member 5 increases expression EXP Rifampin results in increased expression of SLC13A5 mRNA; Rifampin results in increased expression of SLC13A5 protein CTD PMID:25628225 PMID:27199754 NCBI chr17:6,684,719...6,713,369
Ensembl chr17:6,684,719...6,713,377
JBrowse link
G SLC15A1 solute carrier family 15 member 1 decreases expression EXP Rifampin results in decreased expression of SLC15A1 mRNA CTD PMID:27199754 NCBI chr13:98,683,801...98,752,672
Ensembl chr13:98,683,801...98,752,672
JBrowse link
G SLC16A12 solute carrier family 16 member 12 increases expression
decreases expression
EXP Rifampin results in increased expression of SLC16A12 mRNA
Rifampin results in decreased expression of SLC16A12 mRNA
CTD PMID:24552687 PMID:27199754 NCBI chr10:89,430,299...89,556,704
Ensembl chr10:89,430,299...89,556,641
JBrowse link
G SLC17A1 solute carrier family 17 member 1 decreases expression EXP Rifampin results in decreased expression of SLC17A1 mRNA CTD PMID:27199754 NCBI chr 6:25,723,743...25,832,052
Ensembl chr 6:25,782,915...25,832,052
JBrowse link
G SLC1A2 solute carrier family 1 member 2 decreases expression EXP Rifampin results in decreased expression of SLC1A2 mRNA CTD PMID:27199754 NCBI chr11:35,251,205...35,420,507
Ensembl chr11:35,251,205...35,420,063
JBrowse link
G SLC20A2 solute carrier family 20 member 2 decreases expression EXP Rifampin results in decreased expression of SLC20A2 mRNA CTD PMID:27199754 NCBI chr 8:42,416,475...42,541,954
Ensembl chr 8:42,416,475...42,541,926
JBrowse link
G SLC22A1 solute carrier family 22 member 1 multiple interactions
decreases expression
EXP [NR1I2 protein co-treated with Rifampin] results in decreased expression of SLC22A1 mRNA; [NR1I2 protein results in increased susceptibility to Rifampin] which results in decreased expression of SLC22A1 mRNA; NCOA1 protein inhibits the reaction [[NR1I2 protein co-treated with Rifampin] results in decreased expression of SLC22A1 mRNA]; NCOA1 protein inhibits the reaction [[NR1I2 protein results in increased susceptibility to Rifampin] which results in decreased expression of SLC22A1 mRNA]; Rifampin inhibits the reaction [NCOA1 protein binds to SLC22A1 promoter]; Rifampin promotes the reaction [NR1I2 protein results in decreased expression of SLC22A1 mRNA]
Rifampin results in decreased expression of SLC22A1 mRNA; Rifampin results in decreased expression of SLC22A1 protein
CTD PMID:26920453 PMID:27199754 NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,158,718
JBrowse link
G SLC22A7 solute carrier family 22 member 7 decreases expression EXP Rifampin results in decreased expression of SLC22A7 mRNA CTD PMID:16837569 PMID:27199754 NCBI chr 6:43,295,714...43,305,538
Ensembl chr 6:43,295,694...43,305,538
JBrowse link
G SLC22A9 solute carrier family 22 member 9 decreases expression EXP Rifampin results in decreased expression of SLC22A9 mRNA CTD PMID:27199754 NCBI chr11:63,369,785...63,410,294
Ensembl chr11:63,369,785...63,410,294
JBrowse link
G SLC23A2 solute carrier family 23 member 2 increases expression EXP Rifampin results in increased expression of SLC23A2 mRNA CTD PMID:27199754 NCBI chr20:4,852,358...5,010,313
Ensembl chr20:4,852,356...5,010,293
JBrowse link
G SLC23A3 solute carrier family 23 member 3 decreases expression EXP Rifampin results in decreased expression of SLC23A3 mRNA CTD PMID:27199754 NCBI chr 2:219,161,465...219,170,029
Ensembl chr 2:219,161,465...219,170,095
JBrowse link
G SLC25A22 solute carrier family 25 member 22 increases expression EXP Rifampin results in increased expression of SLC25A22 mRNA CTD PMID:27199754 NCBI chr11:790,475...798,281
Ensembl chr11:790,475...798,281
JBrowse link
G SLC25A34 solute carrier family 25 member 34 decreases expression EXP Rifampin results in decreased expression of SLC25A34 mRNA CTD PMID:27199754 NCBI chr 1:15,736,258...15,741,392
Ensembl chr 1:15,736,258...15,741,392
JBrowse link
G SLC25A40 solute carrier family 25 member 40 decreases expression EXP Rifampin results in decreased expression of SLC25A40 mRNA CTD PMID:24552687 NCBI chr 7:87,833,568...87,876,360
Ensembl chr 7:87,833,568...87,876,360
JBrowse link
G SLC26A2 solute carrier family 26 member 2 decreases expression EXP Rifampin results in decreased expression of SLC26A2 mRNA CTD PMID:27199754 NCBI chr 5:149,960,758...149,987,400
Ensembl chr 5:149,960,758...149,993,455
JBrowse link
G SLC26A4 solute carrier family 26 member 4 decreases expression EXP Rifampin results in decreased expression of SLC26A4 mRNA CTD PMID:27199754 NCBI chr 7:107,660,828...107,717,809
Ensembl chr 7:107,660,828...107,717,809
JBrowse link
G SLC27A1 solute carrier family 27 member 1 increases expression ISO Rifampin results in increased expression of SLC27A1 mRNA CTD PMID:27806127 NCBI chr19:17,468,767...17,506,168
Ensembl chr19:17,468,769...17,506,168
JBrowse link
G SLC27A2 solute carrier family 27 member 2 increases expression EXP Rifampin results in increased expression of SLC27A2 mRNA CTD PMID:27199754 NCBI chr15:50,182,196...50,236,385
Ensembl chr15:50,182,196...50,236,385
JBrowse link
G SLC27A3 solute carrier family 27 member 3 decreases expression EXP Rifampin results in decreased expression of SLC27A3 mRNA CTD PMID:27199754 NCBI chr 1:153,775,407...153,780,157
Ensembl chr 1:153,774,354...153,780,157
JBrowse link
G SLC27A5 solute carrier family 27 member 5 increases expression EXP Rifampin results in increased expression of SLC27A5 mRNA CTD PMID:27199754 NCBI chr19:58,498,333...58,511,992
Ensembl chr19:58,479,512...58,512,413
JBrowse link
G SLC29A1 solute carrier family 29 member 1 (Augustine blood group) increases expression EXP Rifampin results in increased expression of SLC29A1 mRNA CTD PMID:27199754 NCBI chr 6:44,219,615...44,234,142
Ensembl chr 6:44,219,553...44,234,142
JBrowse link
G SLC29A4 solute carrier family 29 member 4 increases expression EXP Rifampin results in increased expression of SLC29A4 mRNA CTD PMID:27199754 NCBI chr 7:5,282,943...5,306,912
Ensembl chr 7:5,274,369...5,306,912
JBrowse link
G SLC2A12 solute carrier family 2 member 12 increases expression EXP Rifampin results in increased expression of SLC2A12 mRNA CTD PMID:27199754 NCBI chr 6:133,987,581...134,052,624
Ensembl chr 6:133,987,581...134,052,624
JBrowse link
G SLC2A2 solute carrier family 2 member 2 multiple interactions
decreases expression
EXP NR1I2 protein promotes the reaction [Rifampin results in decreased expression of SLC2A2 protein]
Rifampin results in decreased expression of SLC2A2 mRNA; Rifampin results in decreased expression of SLC2A2 protein
CTD PMID:26616219 PMID:27199754 PMID:34689256 NCBI chr 3:170,996,347...171,026,720
Ensembl chr 3:170,996,347...171,026,743
JBrowse link
G SLC30A10 solute carrier family 30 member 10 decreases expression EXP Rifampin results in decreased expression of SLC30A10 mRNA CTD PMID:27199754 NCBI chr 1:219,910,445...219,959,098
Ensembl chr 1:219,685,427...219,959,018
JBrowse link
G SLC38A2 solute carrier family 38 member 2 decreases expression EXP Rifampin results in decreased expression of SLC38A2 mRNA CTD PMID:27199754 NCBI chr12:46,358,188...46,372,773
Ensembl chr12:46,358,188...46,372,773
JBrowse link
G SLC3A1 solute carrier family 3 member 1 decreases expression EXP Rifampin results in decreased expression of SLC3A1 mRNA CTD PMID:27199754 NCBI chr 2:44,275,480...44,322,437
Ensembl chr 2:44,275,458...44,321,494
JBrowse link
G SLC46A3 solute carrier family 46 member 3 increases expression EXP Rifampin results in increased expression of SLC46A3 mRNA CTD PMID:27199754 NCBI chr13:28,700,080...28,718,970
Ensembl chr13:28,700,064...28,718,970
JBrowse link
G SLC47A1 solute carrier family 47 member 1 increases expression EXP Rifampin results in increased expression of SLC47A1 mRNA CTD PMID:27199754 NCBI chr17:19,533,854...19,579,034
Ensembl chr17:19,495,385...19,579,034
JBrowse link
G SLC51A solute carrier family 51 subunit alpha increases expression EXP Rifampin results in increased expression of SLC51A mRNA CTD PMID:27199754 NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
JBrowse link
G SLC51B solute carrier family 51 subunit beta increases expression EXP Rifampin results in increased expression of SLC51B mRNA CTD PMID:27199754 NCBI chr15:65,045,387...65,053,397
Ensembl chr15:65,045,387...65,053,397
JBrowse link
G SLC5A11 solute carrier family 5 member 11 increases expression EXP Rifampin results in increased expression of SLC5A11 mRNA CTD PMID:27199754 NCBI chr16:24,845,963...24,911,626
Ensembl chr16:24,845,841...24,911,628
JBrowse link
G SLC5A12 solute carrier family 5 member 12 increases expression EXP Rifampin results in increased expression of SLC5A12 mRNA CTD PMID:27199754 NCBI chr11:26,667,020...26,723,389
Ensembl chr11:26,667,020...26,723,427
JBrowse link
G SLC6A12 solute carrier family 6 member 12 increases expression EXP Rifampin results in increased expression of SLC6A12 mRNA CTD PMID:27199754 NCBI chr12:183,848...214,157
Ensembl chr12:190,077...214,570
JBrowse link
G SLC6A20 solute carrier family 6 member 20 increases expression EXP Rifampin results in increased expression of SLC6A20 mRNA CTD PMID:27199754 NCBI chr 3:45,755,449...45,796,536
Ensembl chr 3:45,755,449...45,796,536
JBrowse link
G SLC6A9 solute carrier family 6 member 9 increases expression EXP Rifampin results in increased expression of SLC6A9 mRNA CTD PMID:27199754 NCBI chr 1:43,996,483...44,031,462
Ensembl chr 1:43,991,500...44,031,467
JBrowse link
G SLC9A8 solute carrier family 9 member A8 increases expression EXP Rifampin results in increased expression of SLC9A8 mRNA CTD PMID:27199754 NCBI chr20:49,812,828...49,892,242
Ensembl chr20:49,812,713...49,892,242
JBrowse link
G SLCO1A2 solute carrier organic anion transporter family member 1A2 decreases activity
multiple interactions
ISO Rifampin results in decreased activity of SLCO1A4 protein
Rifampin inhibits the reaction [SLCO1A4 protein results in increased uptake of Digoxin]
CTD PMID:11883641 NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,594
JBrowse link
G SLCO1B1 solute carrier organic anion transporter family member 1B1 affects uptake
decreases activity
multiple interactions
increases expression
EXP SLCO1B1 protein affects the uptake of Rifampin
Rifampin results in decreased activity of SLCO1B1 protein
[Rifampin results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Fluvastatin; Rifampin inhibits the reaction [SLCO1B1 protein results in increased import of estradiol-17 beta-glucuronide]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased import of Taurocholic Acid]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of and results in increased susceptibility to cerivastatin]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of and results in increased susceptibility to cyanoginosin LR]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of and results in increased susceptibility to Fluvastatin]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of and results in increased susceptibility to pitavastatin]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of and results in increased susceptibility to Pravastatin]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of and results in increased susceptibility to Rosuvastatin Calcium]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of estradiol-17 beta-glucuronide]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of estrone sulfate]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of Mesalamine]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of Sulfobromophthalein]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of Ursodeoxycholic Acid metabolite]
Rifampin results in increased expression of SLCO1B1 mRNA
CTD PMID:15652233 PMID:15670600 PMID:16479312 PMID:16837569 PMID:21430235 More... NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796
JBrowse link
G SLCO1B3 solute carrier organic anion transporter family member 1B3 multiple interactions
decreases activity
decreases expression
EXP Rifampin inhibits the reaction [SLCO1B3 protein results in increased import of cyanoginosin LR]; Rifampin inhibits the reaction [SLCO1B3 protein results in increased uptake of estradiol-17 beta-glucuronide]; Rifampin inhibits the reaction [SLCO1B3 protein results in increased uptake of fexofenadine]; Rifampin inhibits the reaction [SLCO1B3 protein results in increased uptake of Hydroxyurea]; Rifampin inhibits the reaction [SLCO1B3 protein results in increased uptake of Mesalamine]; Rifampin inhibits the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein]; Rifampin inhibits the reaction [SLCO1B3 protein results in increased uptake of Ursodeoxycholic Acid metabolite]
Rifampin results in decreased activity of SLCO1B3 protein
Rifampin results in decreased expression of SLCO1B3 mRNA
CTD PMID:17369605 PMID:18180276 PMID:21256917 PMID:21430235 PMID:27199754 More... NCBI chr12:20,810,705...20,916,911
Ensembl chr12:20,810,702...20,916,911
JBrowse link
G SLCO2A1 solute carrier organic anion transporter family member 2A1 multiple interactions EXP Rifampin inhibits the reaction [decitabine results in increased expression of SLCO2A1 mRNA] CTD PMID:23137910 NCBI chr 3:133,932,701...134,029,925
Ensembl chr 3:133,932,701...134,052,184
JBrowse link
G SLCO2B1 solute carrier organic anion transporter family member 2B1 multiple interactions
increases expression
EXP Rifampin inhibits the reaction [SLCO2B1 protein results in increased uptake of Mesalamine]; Rifampin inhibits the reaction [SLCO2B1 protein results in increased uptake of Sulfobromophthalein]
Rifampin results in increased expression of SLCO2B1 mRNA
CTD PMID:21430235 PMID:27199754 NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549
JBrowse link
G SLCO4C1 solute carrier organic anion transporter family member 4C1 increases expression EXP Rifampin results in increased expression of SLCO4C1 mRNA CTD PMID:27199754 NCBI chr 5:102,233,986...102,296,284
Ensembl chr 5:102,233,986...102,296,284
JBrowse link
G SMAD9 SMAD family member 9 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of SMAD9 mRNA CTD PMID:21127053 NCBI chr13:36,844,831...36,920,854
Ensembl chr13:36,844,831...36,920,765
JBrowse link
G SNCA synuclein alpha multiple interactions
increases sumoylation
ISO Rifampin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SNCA protein modified form]; UBE2I affects the reaction [Rifampin results in increased sumoylation of SNCA protein] CTD PMID:17280646 PMID:28132806 NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
JBrowse link
G SNORA71C small nucleolar RNA, H/ACA box 71C decreases expression EXP Rifampin results in decreased expression of SNORA71C mRNA CTD PMID:24552687 NCBI chr20:38,429,667...38,429,804
Ensembl chr20:38,429,670...38,429,803
JBrowse link
G SOCS3 suppressor of cytokine signaling 3 multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of SOCS3 mRNA CTD PMID:21127053 NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
JBrowse link
G SORBS1 sorbin and SH3 domain containing 1 decreases expression EXP Rifampin results in decreased expression of SORBS1 mRNA CTD PMID:24552687 NCBI chr10:95,311,773...95,561,371
Ensembl chr10:95,311,771...95,561,414
JBrowse link
G SPTB spectrin beta, erythrocytic increases expression EXP Rifampin results in increased expression of SPTB mRNA CTD PMID:24552687 NCBI chr14:64,746,283...64,879,907
Ensembl chr14:64,746,283...64,879,907
JBrowse link
G SQSTM1 sequestosome 1 increases expression EXP Rifampin results in increased expression of SQSTM1 protein CTD PMID:29908302 NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
JBrowse link
G SRC SRC proto-oncogene, non-receptor tyrosine kinase multiple interactions EXP [SRC protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA; allyl isothiocyanate inhibits the reaction [[SRC protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]; allyl isothiocyanate inhibits the reaction [NR1I2 protein promotes the reaction [[SRC protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA]]; NR1I2 protein promotes the reaction [[SRC protein co-treated with Rifampin] results in increased expression of CYP3A4 mRNA] CTD PMID:25069801 NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050
JBrowse link
G STAT5A signal transducer and activator of transcription 5A multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in decreased expression of STAT5A mRNA CTD PMID:21127053 NCBI chr17:42,287,547...42,311,943
Ensembl chr17:42,287,547...42,311,943
JBrowse link
G STK39 serine/threonine kinase 39 increases expression EXP Rifampin results in increased expression of STK39 mRNA CTD PMID:24552687 NCBI chr 2:167,954,022...168,247,595
Ensembl chr 2:167,954,020...168,247,595
JBrowse link
G SULT1E1 sulfotransferase family 1E member 1 multiple interactions EXP [NR1I2 protein co-treated with Rifampin] results in decreased expression of SULT1E1 mRNA; [Rifampin results in increased activity of NR1I2 protein] inhibits the reaction [HNF4A protein binds to SULT1E1 enhancer]; Rifampin inhibits the reaction [HNF4A protein binds to SULT1E1 enhancer] CTD PMID:21764778 NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145
JBrowse link
G SULT2A1 sulfotransferase family 2A member 1 multiple interactions ISO [Rifampin promotes the reaction [[NR1I2 protein co-treated with RXRA protein] binds to SULT2A1 promoter]] which results in increased expression of SULT2A1 mRNA; Rifampin promotes the reaction [[NR1I2 protein co-treated with RXRA protein] binds to SULT2A1 promoter] CTD PMID:12370413 NCBI chr19:47,870,467...47,886,315
Ensembl chr19:47,870,467...47,886,315
JBrowse link
G SUMO1 small ubiquitin like modifier 1 increases expression ISO Rifampin results in increased expression of SUMO1 protein CTD PMID:28132806 NCBI chr 2:202,206,171...202,238,597
Ensembl chr 2:202,206,182...202,238,599
JBrowse link
G SUMO3 small ubiquitin like modifier 3 multiple interactions EXP Rifampin inhibits the reaction [trichostatin A inhibits the reaction [[PIAS1 co-treated with SUMO3] inhibits the reaction [NCOR2 protein promotes the reaction [NR1I2 protein binds to HDAC3 protein]]]] CTD PMID:26883953 NCBI chr21:44,805,617...44,818,062
Ensembl chr21:44,805,617...44,818,779
JBrowse link
G SUN1 Sad1 and UNC84 domain containing 1 decreases expression EXP Rifampin results in decreased expression of SUN1 mRNA CTD PMID:24552687 NCBI chr 7:815,557...874,934
Ensembl chr 7:816,615...896,435
JBrowse link
G TBATA thymus, brain and testes associated decreases expression EXP Rifampin results in decreased expression of TBATA mRNA CTD PMID:24552687 NCBI chr10:70,771,238...70,785,377
Ensembl chr10:70,771,238...70,785,401
JBrowse link
G TFEC transcription factor EC increases expression EXP Rifampin results in increased expression of TFEC mRNA CTD PMID:24552687 NCBI chr 7:115,935,152...116,159,896
Ensembl chr 7:115,935,148...116,159,896
JBrowse link
G THSD4 thrombospondin type 1 domain containing 4 increases expression EXP Rifampin results in increased expression of THSD4 mRNA CTD PMID:24552687 NCBI chr15:71,096,894...71,783,383
Ensembl chr15:71,096,952...71,783,383
JBrowse link
G TJP1 tight junction protein 1 affects localization
decreases expression
ISO Rifampin affects the localization of TJP1 protein
Rifampin results in decreased expression of TJP1 mRNA
CTD PMID:19577586 NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
JBrowse link
G TJP2 tight junction protein 2 decreases expression ISO Rifampin results in decreased expression of TJP2 mRNA CTD PMID:19577586 NCBI chr 9:69,121,264...69,255,208
Ensembl chr 9:69,121,264...69,274,615
JBrowse link
G TLR1 toll like receptor 1 increases expression EXP Rifampin results in increased expression of TLR1 mRNA CTD PMID:24552687 NCBI chr 4:38,787,569...38,805,644
Ensembl chr 4:38,790,677...38,856,817
JBrowse link
G TMEM120B transmembrane protein 120B decreases expression EXP Rifampin results in decreased expression of TMEM120B mRNA CTD PMID:24552687 NCBI chr12:121,712,752...121,782,068
Ensembl chr12:121,712,752...121,783,001
JBrowse link
G TMEM145 transmembrane protein 145 increases expression EXP Rifampin results in increased expression of TMEM145 mRNA CTD PMID:24552687 NCBI chr19:42,313,309...42,325,064
Ensembl chr19:42,313,309...42,325,064
JBrowse link
G TMEM88 transmembrane protein 88 increases expression EXP Rifampin results in increased expression of TMEM88 mRNA CTD PMID:24552687 NCBI chr17:7,855,066...7,856,099
Ensembl chr17:7,855,066...7,856,099
JBrowse link
G TMPRSS2 transmembrane serine protease 2 increases expression EXP Rifampin results in increased expression of TMPRSS2 mRNA CTD PMID:32808185 NCBI chr21:41,464,305...41,508,158
Ensembl chr21:41,464,300...41,531,116
JBrowse link
G TNF tumor necrosis factor decreases expression EXP Rifampin results in decreased expression of TNF protein CTD PMID:21357946 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TNFRSF10A TNF receptor superfamily member 10a multiple interactions ISO [Rifampin co-treated with Cobicistat] results in increased expression of TNFRSF10B mRNA CTD PMID:33629115 NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102
JBrowse link
G TNFSF10 TNF superfamily member 10 multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TNFSF10 mRNA CTD PMID:21224054 NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
JBrowse link
G TRADD TNFRSF1A associated via death domain multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TRADD mRNA CTD PMID:21224054 NCBI chr16:67,154,185...67,159,909
Ensembl chr16:67,154,185...67,159,909
JBrowse link
G TRIM51 tripartite motif-containing 51 decreases expression EXP Rifampin results in decreased expression of TRIM51 mRNA CTD PMID:24552687 NCBI chr11:55,883,297...55,891,810
Ensembl chr11:55,883,297...55,891,810
JBrowse link
G TSKU tsukushi, small leucine rich proteoglycan increases expression EXP Rifampin results in increased expression of TSKU mRNA CTD PMID:24552687 PMID:27177772 NCBI chr11:76,782,280...76,798,144
Ensembl chr11:76,782,251...76,798,153
JBrowse link
G UBE2I ubiquitin conjugating enzyme E2 I multiple interactions ISO UBE2I affects the reaction [Rifampin results in increased sumoylation of SNCA protein] CTD PMID:28132806 NCBI chr16:1,309,152...1,327,017
Ensembl chr16:1,308,880...1,327,018
JBrowse link
G UGDH UDP-glucose 6-dehydrogenase multiple interactions
increases expression
EXP [Rifampin co-treated with PPARA protein co-treated with RXRA protein] results in decreased expression of UGDH mRNA
Rifampin results in increased expression of UGDH mRNA
CTD PMID:16292757 NCBI chr 4:39,498,755...39,527,439
Ensembl chr 4:39,498,755...39,528,311
JBrowse link
G UGT1A1 UDP glucuronosyltransferase family 1 member A1 affects expression
increases expression
multiple interactions
EXP Rifampin affects the expression of UGT1A1 mRNA
Rifampin results in increased expression of UGT1A1 mRNA
[Rifampin co-treated with NR1I2 protein] results in increased expression of UGT1A1 mRNA; [Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of UGT1A1 mRNA
CTD PMID:15104253 PMID:15771232 PMID:15849716 PMID:18098064 PMID:22126990 More... NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
JBrowse link
G UGT1A3 UDP glucuronosyltransferase family 1 member A3 increases expression
multiple interactions
EXP Rifampin results in increased expression of UGT1A3 mRNA
pimecrolimus inhibits the reaction [Rifampin results in increased expression of UGT1A3 mRNA]
CTD PMID:25313206 PMID:29356861 NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300
JBrowse link
G UGT1A6 UDP glucuronosyltransferase family 1 member A6 increases expression EXP Rifampin results in increased expression of UGT1A6 mRNA CTD PMID:18094037 NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
JBrowse link
G UGT1A9 UDP glucuronosyltransferase family 1 member A9 increases expression EXP Rifampin results in increased expression of UGT1A9 mRNA; Rifampin results in increased expression of UGT1A9 protein CTD PMID:25070100 NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300
JBrowse link
G UHRF2 ubiquitin like with PHD and ring finger domains 2 decreases expression EXP Rifampin results in decreased expression of UHRF2 mRNA CTD PMID:24552687 NCBI chr 9:6,413,199...6,507,054
Ensembl chr 9:6,413,151...6,507,054
JBrowse link
G UNG uracil DNA glycosylase multiple interactions ISO [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of UNG mRNA CTD PMID:21224054 NCBI chr12:109,097,597...109,110,992
Ensembl chr12:109,097,597...109,110,992
JBrowse link
G USP17L2 ubiquitin specific peptidase 17 like family member 2 decreases expression EXP Rifampin results in decreased expression of USP17L2 mRNA CTD PMID:24552687 NCBI chr 8:12,136,435...12,138,849
Ensembl chr 8:12,136,435...12,138,849
JBrowse link
G VEGFA vascular endothelial growth factor A increases expression ISO Rifampin results in increased expression of VEGFA protein CTD PMID:25051504 NCBI chr 6:43,770,209...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
G VEGFD vascular endothelial growth factor D multiple interactions EXP [Rifampin co-treated with NR1I2 protein] results in increased expression of VEGFD mRNA CTD PMID:21127053 NCBI chr  X:15,345,596...15,384,413
Ensembl chr  X:15,345,596...15,384,413
JBrowse link